WO2017148418A1 - Method for determining component contents of chinese medicine composition - Google Patents

Method for determining component contents of chinese medicine composition Download PDF

Info

Publication number
WO2017148418A1
WO2017148418A1 PCT/CN2017/075456 CN2017075456W WO2017148418A1 WO 2017148418 A1 WO2017148418 A1 WO 2017148418A1 CN 2017075456 W CN2017075456 W CN 2017075456W WO 2017148418 A1 WO2017148418 A1 WO 2017148418A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
methanol
solution
chlorogenic acid
quercetin
Prior art date
Application number
PCT/CN2017/075456
Other languages
French (fr)
Chinese (zh)
Inventor
陈育鹏
毕丹
赵倩
张水英
叶玉廷
任晋
魏峰
Original Assignee
石家庄以岭药业股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 石家庄以岭药业股份有限公司 filed Critical 石家庄以岭药业股份有限公司
Publication of WO2017148418A1 publication Critical patent/WO2017148418A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/19Acanthaceae (Acanthus family)
    • A61K36/195Strobilanthes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315Isatis, e.g. Dyer's woad
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/41Crassulaceae (Stonecrop family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/78Saururaceae (Lizard's-tail family)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Definitions

  • the invention relates to a method for determining the content of a traditional Chinese medicine composition, and belongs to the technical field of quality control methods for medicines.
  • Traditional Chinese medicine is the most important material means for Chinese medicine to prevent and cure diseases.
  • the modernization of traditional Chinese medicine that has been implemented since the "Ninth Five-Year Plan" in China is a major measure to promote the development of the Chinese medicine industry.
  • the quality control and evaluation of traditional Chinese medicine is one of the key issues in the modernization of traditional Chinese medicine, and it is also a difficult point and hot spot in the research of traditional Chinese medicine.
  • the purpose of quality control of traditional Chinese medicine is to ensure the effectiveness and safety of traditional Chinese medicine.
  • the quality control of traditional Chinese medicine is to monitor the pharmacodynamic substances, toxic substances and their changing laws of traditional Chinese medicine. It is based on a series of quality standards to conduct quality inspection and control on every link in the production process of traditional Chinese medicine.
  • Liquid chromatography has a high degree of separation, which can separate complex chemical components to form different chromatograms.
  • the height and peak area of these peaks represent various chemical components and their contents. Its content can effectively reflect the quality of the product and its stability.
  • the content determination method is mainly composed of a single component, and there is rarely one method for simultaneously determining the content determination method of a plurality of active ingredients.
  • the invention claims a method for determining the content of a traditional Chinese medicine composition, which comprises the following herbs: forsythia, honeysuckle, radix isatidis, bitter almond, menthol, houttuynia, rhubarb, patchouli, and cotton horse , Rhodiola, Ephedra, Licorice, Gypsum, the content determination method, simultaneous determination of new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl
  • the content of seven components of linic acid, quercetin and glycyrrhizic acid can effectively save energy and reduce the analysis cost, and the technical content is not disclosed in the prior art.
  • the invention provides a method for determining the content of a traditional Chinese medicine composition.
  • the method can simultaneously determine various active ingredients in the traditional Chinese medicine composition.
  • the raw material medicine of the traditional Chinese medicine composition comprises: forsythia, ephedra, rhubarb, houttuynia, honeysuckle, radix isatidis, patchouli, Mianma Guanzhong, Rhodiola, menthol, Bitter almond, licorice, gypsum, characterized in that the content determination method comprises the following steps:
  • test solution taking the traditional Chinese medicine composition, and extracting with an organic solvent to obtain a test solution;
  • Preparation of reference solution take appropriate amount of chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate , dissolved in an organic solvent to obtain a reference solution;
  • Chromatographic conditions using a methanol-acetonitrile-phosphoric acid aqueous solution ternary solvent system as a mobile phase, gradient elution, the concentration of the aqueous phosphoric acid solution is 0.1% to 0.5%;
  • Determination method separately draw the reference solution and the test solution, inject into the liquid chromatograph, and measure, that is, obtain.
  • the organic solvent comprises 50% to 100% methanol solution, 50% to 100% ethanol solution.
  • the gradient elution procedure is:
  • the detection wavelengths are 327 nm and 250 nm, respectively; quercetin and glycyrrhizic acid are detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5- are detected at 327 nm. Di-O-caffeoylquinic acid.
  • the present invention provides a method for determining the content of a traditional Chinese medicine composition, which is prepared from the following raw materials by weight: Forsythia 200-300, Ephedra 60-100, Rhubarb 40-60, Houttuynia cordata 200-300, honeysuckle 200-300, Ban GmbH 200-300, patchouli 60-100, cotton horse Guanzhong 200-300, Rhodiola 60-100, menthol 5-9, bitter almond 60-100, licorice 60-100, gypsum 200-300, the content determination method is as follows:
  • test solution Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of ethanol or methanol, extract it by ultrasonic or reflux for 30 minutes, filter, obtain the filtrate, and evaporate. The residue is dissolved in ethanol or methanol and made up to 25 mL, which is obtained;
  • the detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm.
  • Determination method respectively, accurately draw 2 ⁇ L of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 200, Honeysuckle 300, Ban GmbH 200, Rhubarb 40, Patchouli 60, Mianma Guanzhong 300, Rhodiola 100, Menthol 9, Ephedra 60, bitter almond 100, houttuynia cordica 200, licorice 100, gypsum 200.
  • the preferred parts of the traditional Chinese medicine composition of the present invention are: Forsythia 300, Honeysuckle 200, Ban GmbH 300, Rhubarb 60, Patchouli 100, Mianma Guanzhong 200, Rhodiola 60, Menthol 5, Ephedra 100, bitter almond 60, houttuyniasis 300, licorice 60, gypsum 300.
  • the preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 278, Honeysuckle 294, Radix Isatidis 285, Rhubarb 55, Patchouli 95, Mianma Guanzhong 290, Rhodiola 87, Menthol 8.5, Ephedra 88, bitter almond 80, houttuynia 284, licorice 95, gypsum 277.
  • the preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 255, Honeysuckle 255, Radix Isatidis 255, Rhubarb 51, Patchouli 85, Mian Ma Guan 255, Rhodiola 85, Menthol 7.5, Ephedra 85 , bitter almond 85, houttuynia 255, licorice 85, gypsum 255.
  • the preparation method of the traditional Chinese medicine composition preparation of the invention is:
  • the volatile oil obtained in the step (2) is dissolved in ethanol, sprayed into the granules obtained in the step (6), sealed, mixed, tableted or encapsulated, or Bagging.
  • the content determination method according to the present invention is preferably:
  • test solution Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 50mL ethanol, 25mL, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, The filtrate was obtained, and the filter paper was added together with the residue into a stoppered conical flask, and 25 mL of 50% ethanol was added thereto, sonicated for 30 minutes, filtered, and the dregs were washed 4 times with 50% ethanol, 5 mL each time, and the filtrate and washing were combined twice. The liquid is evaporated to dryness, and the residue is dissolved in 50% methanol and made up to 25 mL, which is obtained;
  • the detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm.
  • Determination method respectively, accurately draw 2 ⁇ L of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the content determination method according to the present invention is also preferably:
  • test solution Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 50% methanol 25mL, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, The filtrate was obtained, and the filter paper was added together with the residue into a stoppered conical flask, and then 50 mL of 50% methanol was added thereto, sonicated for 30 minutes, filtered, and the dregs were washed 4 times with 50% methanol, 5 mL each time, and the filtrate and washing were combined twice. The liquid is evaporated to dryness, and the residue is dissolved in 50% methanol and made up to 25 mL, which is obtained;
  • the detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm.
  • Determination method respectively, accurately draw 2 ⁇ L of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the content determination method according to the present invention is also preferably:
  • test solution Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of methanol, reflux extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, and obtain filtrate Add the filter paper together with the residue into a stoppered conical flask, add 25mL of methanol, sonicate for 30 minutes, filter, wash the dregs with methanol 4 times, each time 5mL, combine the filtrate and washing solution twice, evaporate and dry, residue Dissolve with 50% methanol and dilute to 25mL, that is;
  • the detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm.
  • Determination method respectively, accurately draw 2 ⁇ L of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the content determination method of the present invention is also preferably:
  • test solution Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of ethanol, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, and obtain filtrate Add the filter paper together with the residue into the stoppered conical flask, add 25mL of ethanol, sonicate for 30 minutes, filter, wash the dregs with ethanol 4 times, each time 5mL, combine the filtrate and washing solution twice, evaporate and dry, residue Dissolve with 50% methanol and dilute to 25mL, that is;
  • the detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm.
  • Determination method respectively, accurately draw 2 ⁇ L of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • Example 1 Using the sample prepared in Example 1, the method for determining the content of the present invention evaluates the feasibility of the method from various aspects, and the evaluation method is as follows:
  • Ethanol (analytical grade, Tianjin Guangfu Technology Development Co., Ltd.), phosphoric acid (analytical grade, Tianjin Guangfu Technology Development Co., Ltd.), acetonitrile (chromatographically pure, Fisher Company, USA), methanol (chromatographically pure, Fisher Company, USA), new green Acid (Chengdu Puruifa Technology Development Co., Ltd., batch number: 13112712, purity ⁇ 98%), chlorogenic acid (China Food and Drug Testing Institute, batch number: 110753-201314, purity, 96.6%), cryptochlorogenic acid (Shanghai Source Leaf Biotechnology Co., Ltd., batch number: ZF0226BA14, purity ⁇ 98%), isophoric acid ester A (Shanghai Yuanye Biotechnology Co., Ltd., batch number: YA0817HB14, purity ⁇ 98%), 4,5-di-O- Caffeoylquinic acid (China Food and Drug Control Institute, batch number: 111894-2011
  • the maximum absorption peak at 327 nm and 250 nm was selected as the detection wavelength, and the new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4 were detected at 327 nm.
  • 5-di-O-caffeoylquinic acid, quercetin and glycyrrhizic acid were detected at 250 nm to minimize interference from other components.
  • a methanol-acetonitrile-0.1% phosphoric acid solution was used as a mobile phase, and a gradient elution was carried out according to the above table.
  • the detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm.
  • the mixture was filtered, and the dregs were washed 4 times with 5 ml each time, and the washing liquid and the filtrate were combined, evaporated to dryness, and the residue was dissolved in 50% methanol and made up to 25 ml, as a test solution.
  • the experimental results show that the reflux extraction is slightly higher than the ultrasonic extraction peak area, and can be used as the extraction method of the traditional Chinese medicine composition of the present invention.
  • Dilute the mixed reference solution of the component to be tested into a series of solutions perform UPLC detection, record the ratio of signal intensity to noise intensity, and use the concentration of signal intensity and noise intensity equal to 3 as the detection limit, and the signal intensity and The concentration at which the noise intensity ratio is equal to 10 is taken as the limit of quantification.
  • the detection limits of new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, quercetin, 4,5-di-O-caffeoylquinic acid and glycyrrhizic acid were determined to be 0.051 ⁇ g/ mL, 0.049 ⁇ g/mL, 0.052 ⁇ g/mL, 0.111 ⁇ g/mL, 0.037 ⁇ g/mL, 0.049 ⁇ g/mL, and 2.095 ⁇ g/mL; the limits of quantification were 0.156 ⁇ g/mL, 0.147 ⁇ g/mL, and 0.157 ⁇ g/mL, respectively. 0.337 ⁇ g/mL, 0.112 ⁇ g/mL, 0.149 ⁇ g/mL, and 6.200 ⁇ g/mL.
  • the RSD of the peak area of the component to be tested is less than 2%, indicating that the precision of the instrument is good.
  • test solution was accurately taken and injected at room temperature for 0, 2, 4, 6, 8 and 12 hours, respectively.
  • the peak area of the component to be tested was recorded, and the RSD of the peak area was calculated.
  • the stability was investigated. The measurement results are shown in Table 10.
  • test solution was taken, and other chromatographic conditions were fixed, and the flow rates were 0.25 mL/min, 0.3 mL/min, and 0.35 mL/min, respectively, and the contents of the components to be tested were calculated according to the reference materials of the respective components. The effect of the change in flow rate on the measurement results was compared. The results are shown in Table 18.
  • test solution was taken and other chromatographic conditions were fixed and measured at wavelengths of 322, 245 nm, 327, 250 nm, and 332, 255 nm, respectively, and the reference substance of each component to be tested was used as a control to calculate the content of the component to be tested, and to compare wavelength changes. The effect on the measurement results. The results are shown in Table 19.
  • the content of the same batch of the components of the traditional Chinese medicine composition of the present invention is determined by different analysts at different times and using two different UPLC instruments, and each test is operated in parallel for 3 times. Test the sample and examine the intermediate precision. The results are shown in Table 21-25.
  • Table 21 Analyst A uses UPLC (1) to determine the content of the component to be tested
  • Table 24 Analyst B uses UPLC (2) to determine the content of the component to be tested
  • the content of the components to be tested of the three batches of the traditional Chinese medicine composition of the present invention was measured by the determined content determination method, and the results are shown in Table 26.
  • the invention establishes a method for determining the content of seven components in the four herbs of the traditional Chinese medicine composition of the invention, and the methodological research results show that the method has the active ingredients in the four herbs of forsythia, honeysuckle, houttuynia and licorice. Good accuracy, precision, stability and repeatability can effectively control the quality and safety of the traditional Chinese medicine composition.
  • Figure 1 Chromatogram of the reference at 327nm, where 1 is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid A, and 5 is 4,5-di-O-coffee.
  • Figure 3 Chromatogram of the reference at 250 nm, where 6 is quercetin and 7 is glycyrrhizic acid
  • FIG. 5 Chromatogram of Example 1: A is a chromatogram of the reference at 327 nm, where 1 is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid A, 5 is 4,5-di-O-caffeoylquinic acid; B picture is the chromatogram of the test sample at 327nm; C picture is the chromatogram of the reference substance at 250nm, of which 6 is quercetin, 7 is glycyrrhizic acid; Chromatogram of the test sample at 250 nm.
  • Figure 6 Chromatogram of Example 2:
  • Figure A is a chromatogram of the reference substance at 327 nm, where 1 is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid A, 5 is 4,5-di-O-caffeoylquinic acid;
  • B picture is the chromatogram of the test sample at 327nm;
  • C picture is the chromatogram of the reference substance at 250nm, of which 6 is quercetin, 7 is glycyrrhizic acid; Chromatogram of the test sample at 250 nm.
  • Figure 7 Chromatogram of Example 3:
  • Figure A is a chromatogram of the reference substance at 327 nm, where 1 is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid A, 5 is 4,5-di-O-caffeoylquinic acid;
  • B picture is the chromatogram of the test sample at 327nm;
  • C picture is the chromatogram of the reference substance at 250nm, of which 6 is quercetin, 7 is glycyrrhizic acid; Chromatogram of the test sample at 250 nm.
  • Figure 8 Chromatogram of Example 4:
  • Figure A is a chromatogram of the reference substance at 327 nm, where 1 is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid A, 5 is 4,5-di-O-caffeoylquinic acid;
  • B picture is the chromatogram of the test sample at 327nm;
  • C picture is the chromatogram of the reference substance at 250nm, of which 6 is quercetin, 7 is glycyrrhizic acid; Chromatogram of the test sample at 250 nm.
  • test solution Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 50mL ethanol, 25mL, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, The filtrate was obtained, and the filter paper was added together with the residue into a stoppered conical flask, and 25 mL of 50% ethanol was added thereto, sonicated for 30 minutes, filtered, and the dregs were washed 4 times with 50% ethanol, 5 mL each time, and the filtrate and washing were combined twice. The liquid is evaporated to dryness, and the residue is dissolved in 50% methanol and made up to 25 mL, which is obtained;
  • the detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm.
  • Determination method respectively, accurately draw 2 ⁇ L of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • test solution Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 50% methanol 25mL, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, obtain the filtrate, add the filter paper together with the residue into the conical flask, add 50mL methanol 25mL, sonicate for 30 minutes, filter, wash the dregs with 50% methanol 4 times 5mL each time, the filtrate and washing solution were combined twice, evaporated to dryness, and the residue was dissolved in 50% methanol and made up to 25 mL, which was obtained;
  • the detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm.
  • Determination method respectively, accurately draw 2 ⁇ L of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the raw material formula is: Forsythia 278g, Honeysuckle 294g, Radix Isatidis 285g, Rhubarb 55g, Patchouli 95g, Mianma Guanzhong 290g, Rhodiola 87g, Menthol 8.5g, Ephedra 88g, Bitter Almond 80g, Houttuynia 284g , licorice 95g, gypsum 277g, according to the following process:
  • test solution Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of methanol, reflux extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, and obtain filtrate Add the filter paper together with the residue into a stoppered conical flask, add 25mL of methanol, sonicate for 30 minutes, filter, wash the dregs with methanol 4 times, each time 5mL, combine the filtrate and washing solution twice, evaporate and dry, residue Dissolve with 50% methanol and dilute to 25mL, that is;
  • the detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm.
  • Determination method respectively, accurately draw 2 ⁇ L of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the raw material formula is: scaled: 200g of Forsythia, 300g of honeysuckle, 200g of Radix, 60g of rhubarb, 60g of patchouli, 300g of Mianmaguan, 60g of Rhodiola, 9g of menthol, 60g of ephedra, 100g of bitter almond, Houttuynia cordata 200g, licorice 100g, gypsum 200g, extracted according to the following process:
  • test solution Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of ethanol, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, and obtain filtrate Add the filter paper together with the residue into the stoppered conical flask, add 25mL of ethanol, sonicate for 30 minutes, filter, wash the dregs with ethanol 4 times, each time 5mL, combine the filtrate and washing solution twice, evaporate and dry, residue Dissolve with 50% methanol and dilute to 25mL, that is;
  • the detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm.
  • Determination method respectively, accurately draw 2 ⁇ L of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Provided is a method for determining the component contents of a Chinese medicine composition. Raw materials for the Chinese medicine composition consist of forsythia, Japanese honeysuckle, indigowoad root, bitter almond, mentha-camphor, houttuynia cordata, rhubarb, patchouli, male fern rhizome, kirilow rhodiola root and rhizome, ephedra, licorice, and gypsum. The component content determination method uses a high-performance liquid chromatography technique to simultaneously determine the contents of seven components: neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isoforsythiaside A, 4,5-di-O-caffeoylquinic acid, quercitrin, and glycyrrhizic acid ammonium salt. A test sample is extracted by methanol or ethanol. The chromatographic conditions comprise using a methanol/acetonitrile/0.1-0.5% phosphoric acid aqueous solution as a mobile phase to perform a gradient elution, and using two detection wavelengths of 327 nm and 250 nm.

Description

一种中药组合物的含量测定方法Method for determining content of traditional Chinese medicine composition 技术领域Technical field
本发明涉及到一种中药组合物的含量测定方法,属于药品的质量控制方法领域。The invention relates to a method for determining the content of a traditional Chinese medicine composition, and belongs to the technical field of quality control methods for medicines.
背景技术Background technique
中药是中医防病治病的最重要物质手段。我国自“九五”以来开展实施的中药现代化是推动中药产业发展的重大举措。而中药的质量控制和评价是中药现代化的关键问题之一,也是中药研究的难点和热点。中药质量控制的目的是保证中药的有效性和安全性。中药质量控制就是监测中药的药效物质、有毒物质及其变化规律,是依据一系列质量标准对中药生产过程中的每一个环节进行质量检测与控制。而中药质量评价的技术、方法和策略的研究是制订科学、合理、先进的质量标准的基础。液相色谱具有很高的分离度,可把复杂的化学成分进行分离而形成高低不同的峰组成一张色谱图,这些色谱峰的高度和峰面积分别代表了各种不同化学成分和其含量,其含量的大小可以有效的反应产品质量及其稳定性。目前含量测定方法中以单一成分为主,很少有一种方法同时测定多个有效成分的含量测定方法。Traditional Chinese medicine is the most important material means for Chinese medicine to prevent and cure diseases. The modernization of traditional Chinese medicine that has been implemented since the "Ninth Five-Year Plan" in China is a major measure to promote the development of the Chinese medicine industry. The quality control and evaluation of traditional Chinese medicine is one of the key issues in the modernization of traditional Chinese medicine, and it is also a difficult point and hot spot in the research of traditional Chinese medicine. The purpose of quality control of traditional Chinese medicine is to ensure the effectiveness and safety of traditional Chinese medicine. The quality control of traditional Chinese medicine is to monitor the pharmacodynamic substances, toxic substances and their changing laws of traditional Chinese medicine. It is based on a series of quality standards to conduct quality inspection and control on every link in the production process of traditional Chinese medicine. The research on the techniques, methods and strategies of quality evaluation of traditional Chinese medicine is the basis for formulating scientific, reasonable and advanced quality standards. Liquid chromatography has a high degree of separation, which can separate complex chemical components to form different chromatograms. The height and peak area of these peaks represent various chemical components and their contents. Its content can effectively reflect the quality of the product and its stability. At present, the content determination method is mainly composed of a single component, and there is rarely one method for simultaneously determining the content determination method of a plurality of active ingredients.
本发明要求保护一种中药组合物的含量测定方法,该中药组合物由以下药材组成:连翘、金银花、板蓝根、苦杏仁、薄荷脑、鱼腥草、大黄、广藿香、绵马贯众、红景天、麻黄、甘草、石膏,该含量测定方法,同时测定了新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷和甘草酸七个成分的含量,可以有效的节约能源,降低分析成本,而现有技术中并没有公开该技术内容。The invention claims a method for determining the content of a traditional Chinese medicine composition, which comprises the following herbs: forsythia, honeysuckle, radix isatidis, bitter almond, menthol, houttuynia, rhubarb, patchouli, and cotton horse , Rhodiola, Ephedra, Licorice, Gypsum, the content determination method, simultaneous determination of new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl The content of seven components of linic acid, quercetin and glycyrrhizic acid can effectively save energy and reduce the analysis cost, and the technical content is not disclosed in the prior art.
发明内容Summary of the invention
本发明提供一种中药组合物的含量测定方法。该方法可以同时测定所述中药组合物中多种有效成分。The invention provides a method for determining the content of a traditional Chinese medicine composition. The method can simultaneously determine various active ingredients in the traditional Chinese medicine composition.
一种中药组合物的含量测定方法,该中药组合物的原料药包括:连翘、麻黄、大黄、鱼腥草、金银花、板蓝根、广藿香、绵马贯众、红景天、薄荷脑、苦杏仁、甘草、石膏,其特征在于,所述含量测定方法包括如下步骤:A method for determining the content of a traditional Chinese medicine composition, the raw material medicine of the traditional Chinese medicine composition comprises: forsythia, ephedra, rhubarb, houttuynia, honeysuckle, radix isatidis, patchouli, Mianma Guanzhong, Rhodiola, menthol, Bitter almond, licorice, gypsum, characterized in that the content determination method comprises the following steps:
供试品溶液制备:取中药组合物,加有机溶剂提取,得供试品溶液;Preparation of the test solution: taking the traditional Chinese medicine composition, and extracting with an organic solvent to obtain a test solution;
对照品溶液制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,加有机溶剂溶解,得对照品溶液;Preparation of reference solution: take appropriate amount of chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate , dissolved in an organic solvent to obtain a reference solution;
色谱条件:以甲醇-乙腈-磷酸水溶液三元溶剂系统为流动相,梯度洗脱,所述磷酸水溶液浓度为0.1%~0.5%;Chromatographic conditions: using a methanol-acetonitrile-phosphoric acid aqueous solution ternary solvent system as a mobile phase, gradient elution, the concentration of the aqueous phosphoric acid solution is 0.1% to 0.5%;
测定法:分别吸取对照品溶液与供试品溶液,注入液相色谱仪,测定,即得。Determination method: separately draw the reference solution and the test solution, inject into the liquid chromatograph, and measure, that is, obtain.
优选的,所述有机溶剂包括50%~100%的甲醇溶液、50%~100%的乙醇溶液。Preferably, the organic solvent comprises 50% to 100% methanol solution, 50% to 100% ethanol solution.
优选的,所述梯度洗脱程序为:Preferably, the gradient elution procedure is:
Figure PCTCN2017075456-appb-000001
Figure PCTCN2017075456-appb-000001
优选的,所述检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸。Preferably, the detection wavelengths are 327 nm and 250 nm, respectively; quercetin and glycyrrhizic acid are detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5- are detected at 327 nm. Di-O-caffeoylquinic acid.
进一步优选的,本发明提供一种中药组合物的含量测定方法,该中药组合物由如下重量份的原料药制成:连翘200-300、麻黄60-100、大黄40-60、鱼腥草200-300、金银花200-300、板蓝根200-300、广藿香60-100、绵马 贯众200-300、红景天60-100、薄荷脑5-9、苦杏仁60-100、甘草60-100、石膏200-300,含量测定方法如下:Further preferably, the present invention provides a method for determining the content of a traditional Chinese medicine composition, which is prepared from the following raw materials by weight: Forsythia 200-300, Ephedra 60-100, Rhubarb 40-60, Houttuynia cordata 200-300, honeysuckle 200-300, Banlangen 200-300, patchouli 60-100, cotton horse Guanzhong 200-300, Rhodiola 60-100, menthol 5-9, bitter almond 60-100, licorice 60-100, gypsum 200-300, the content determination method is as follows:
供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加乙醇或甲醇25mL,超声或者回流提取30分钟,过滤,得滤液,蒸干,残渣用乙醇或甲醇溶解并定容至25mL,即得;Preparation of the test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of ethanol or methanol, extract it by ultrasonic or reflux for 30 minutes, filter, obtain the filtrate, and evaporate. The residue is dissolved in ethanol or methanol and made up to 25 mL, which is obtained;
对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg 4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg 4,5-two a mixed solution of -O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
Figure PCTCN2017075456-appb-000002
Figure PCTCN2017075456-appb-000002
检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为C18色谱柱;The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; the column is a C 18 column;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
本发明所述的中药组合物优选的重量份原料药为:连翘200、金银花300、板蓝根200、大黄40、广藿香60、绵马贯众300、红景天100、薄荷脑9、麻黄60、苦杏仁100、鱼腥草200、甘草100、石膏200。The preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 200, Honeysuckle 300, Banlangen 200, Rhubarb 40, Patchouli 60, Mianma Guanzhong 300, Rhodiola 100, Menthol 9, Ephedra 60, bitter almond 100, houttuynia cordica 200, licorice 100, gypsum 200.
本发明所述的中药组合物优选的重量份原料药为:连翘300、金银花200、板蓝根300、大黄60、广藿香100、绵马贯众200、红景天60、薄荷脑5、麻黄100、苦杏仁60、鱼腥草300、甘草60、石膏300。The preferred parts of the traditional Chinese medicine composition of the present invention are: Forsythia 300, Honeysuckle 200, Banlangen 300, Rhubarb 60, Patchouli 100, Mianma Guanzhong 200, Rhodiola 60, Menthol 5, Ephedra 100, bitter almond 60, houttuyniasis 300, licorice 60, gypsum 300.
本发明所述的中药组合物优选的重量份原料药为:连翘278、金银花294、板蓝根285、大黄55、广藿香95、绵马贯众290、红景天87、薄荷脑8.5、麻黄88、苦杏仁80、鱼腥草284、甘草95、石膏277。The preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 278, Honeysuckle 294, Radix Isatidis 285, Rhubarb 55, Patchouli 95, Mianma Guanzhong 290, Rhodiola 87, Menthol 8.5, Ephedra 88, bitter almond 80, houttuynia 284, licorice 95, gypsum 277.
本发明所述的中药组合物优选的重量份原料药为:连翘255、金银花255、板蓝根255、大黄51、广藿香85、绵马贯255、红景天85、薄荷脑7.5、麻黄85、苦杏仁85、鱼腥草255、甘草85、石膏255。The preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 255, Honeysuckle 255, Radix Isatidis 255, Rhubarb 51, Patchouli 85, Mian Ma Guan 255, Rhodiola 85, Menthol 7.5, Ephedra 85 , bitter almond 85, houttuynia 255, licorice 85, gypsum 255.
本发明所述的中药组合物制剂的制备方法为:The preparation method of the traditional Chinese medicine composition preparation of the invention is:
(1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
(2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
(3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
(4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
(5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
(6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
(7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,密闭,混匀,压片或者装胶囊、或 者装袋。(7) menthol, the volatile oil obtained in the step (2) is dissolved in ethanol, sprayed into the granules obtained in the step (6), sealed, mixed, tableted or encapsulated, or Bagging.
本发明所述的含量测定方法优选为:The content determination method according to the present invention is preferably:
供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加50%乙醇25mL,超声提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加50%乙醇25mL,超声处理30分钟,过滤,用50%乙醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 50mL ethanol, 25mL, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, The filtrate was obtained, and the filter paper was added together with the residue into a stoppered conical flask, and 25 mL of 50% ethanol was added thereto, sonicated for 30 minutes, filtered, and the dregs were washed 4 times with 50% ethanol, 5 mL each time, and the filtrate and washing were combined twice. The liquid is evaporated to dryness, and the residue is dissolved in 50% methanol and made up to 25 mL, which is obtained;
对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg 4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg 4,5-two a mixed solution of -O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
Figure PCTCN2017075456-appb-000003
Figure PCTCN2017075456-appb-000003
检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱:ACQUITY
Figure PCTCN2017075456-appb-000004
HSS T3(1.8μm,2.1×100mm);柱温为35℃;
The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column: ACQUITY
Figure PCTCN2017075456-appb-000004
HSS T3 (1.8 μm, 2.1 × 100 mm); column temperature is 35 ° C;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
本发明所述的含量测定方法还优选为:The content determination method according to the present invention is also preferably:
供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加50%甲醇25mL,超声提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加50%甲醇25mL,超声处理30分钟,过滤,用50%甲醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 50% methanol 25mL, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, The filtrate was obtained, and the filter paper was added together with the residue into a stoppered conical flask, and then 50 mL of 50% methanol was added thereto, sonicated for 30 minutes, filtered, and the dregs were washed 4 times with 50% methanol, 5 mL each time, and the filtrate and washing were combined twice. The liquid is evaporated to dryness, and the residue is dissolved in 50% methanol and made up to 25 mL, which is obtained;
对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg 4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg 4,5-two a mixed solution of -O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
Figure PCTCN2017075456-appb-000005
Figure PCTCN2017075456-appb-000005
Figure PCTCN2017075456-appb-000006
Figure PCTCN2017075456-appb-000006
检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为ACQUITY
Figure PCTCN2017075456-appb-000007
CSHTMC18
The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column is ACQUITY
Figure PCTCN2017075456-appb-000007
CSH TM C 18 ;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
本发明所述的含量测定方法还优选为:The content determination method according to the present invention is also preferably:
供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加甲醇25mL,回流提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加甲醇25mL,超声处理30分钟,过滤,用甲醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of methanol, reflux extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, and obtain filtrate Add the filter paper together with the residue into a stoppered conical flask, add 25mL of methanol, sonicate for 30 minutes, filter, wash the dregs with methanol 4 times, each time 5mL, combine the filtrate and washing solution twice, evaporate and dry, residue Dissolve with 50% methanol and dilute to 25mL, that is;
对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg 4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg 4,5-two a mixed solution of -O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
Figure PCTCN2017075456-appb-000008
Figure PCTCN2017075456-appb-000008
检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为ACQUITY
Figure PCTCN2017075456-appb-000009
BEHC18
The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column is ACQUITY
Figure PCTCN2017075456-appb-000009
BEHC 18 ;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
本发明所述含量测定方法还优选为:The content determination method of the present invention is also preferably:
供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加乙醇25mL,超声提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加乙醇25mL,超声处理30分钟,过滤,用乙醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of ethanol, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, and obtain filtrate Add the filter paper together with the residue into the stoppered conical flask, add 25mL of ethanol, sonicate for 30 minutes, filter, wash the dregs with ethanol 4 times, each time 5mL, combine the filtrate and washing solution twice, evaporate and dry, residue Dissolve with 50% methanol and dilute to 25mL, that is;
对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg 4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg 4,5-two a mixed solution of -O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
Figure PCTCN2017075456-appb-000010
Figure PCTCN2017075456-appb-000010
Figure PCTCN2017075456-appb-000011
Figure PCTCN2017075456-appb-000011
检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为ACQUITY
Figure PCTCN2017075456-appb-000012
BEHC18
The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column is ACQUITY
Figure PCTCN2017075456-appb-000012
BEHC 18 ;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
用实施例1制备的样品,对本发明含量测定方法,从多个方面评价该方法的可行性,评价方法如下:Using the sample prepared in Example 1, the method for determining the content of the present invention evaluates the feasibility of the method from various aspects, and the evaluation method is as follows:
1.仪器、试剂与试药1. Instruments, reagents and reagents
1.1仪器1.1 Instrument
美国Waters ACQUITY UPLC H-CLASS超高效液相色谱仪(TUV检测器,Empower 3.0色谱工作站),循环式多用真空泵(郑州长城科工贸有限公司),KQ250DB型超声波清洗器(昆山市超声仪器有限公司),瑞士METTLER TOLEDOAL204型电子分析天平,瑞士METTLER TOLEDOAB135-S型电子分析天平,上海精科JA2603B电子天平。US Waters ACQUITY UPLC H-CLASS Ultra High Performance Liquid Chromatograph (TUV Detector, Empower 3.0 Chromatography Workstation), Circulating Multipurpose Vacuum Pump (Zhengzhou Changcheng Branch Industry and Trade Co., Ltd.), KQ250DB Ultrasonic Cleaner (Kunshan Ultrasonic Instrument Co., Ltd.) ), Switzerland METTLER TOLEDOAL204 electronic analytical balance, Switzerland METTLER TOLEDOAB135-S electronic analytical balance, Shanghai Jingke JA2603B electronic balance.
1.2试剂1.2 reagent
乙醇(分析纯,天津市光复科技发展有限公司),磷酸(分析纯,天津市光复科技发展有限公司),乙腈(色谱纯,美国Fisher公司),甲醇(色谱纯,美国Fisher公司),新绿原酸(成都普瑞法科技开发有限公司,批号:13112712,纯度≥98%),绿原酸(中国食品药品检定研究院,批号:110753-201314,纯度,96.6%)、隐绿原酸(上海源叶生物科技有限公司,批号:ZF0226BA14,纯度≥98%)、异连翘酯苷A(上海源叶生物科技有限公司,批号:YA0817HB14,纯度≥98%)、4,5-二-O-咖啡酰奎宁酸(中国食品药品检定研究院,批号:111894-201102,纯度,94.1%)、槲皮苷(HWIANALYTIK GMBH pharma solutions,批号:HWI01112,纯度,91.7%)、甘草酸铵(Council ofEurope-EDQM,批号:1.1,纯度≥98%)。Ethanol (analytical grade, Tianjin Guangfu Technology Development Co., Ltd.), phosphoric acid (analytical grade, Tianjin Guangfu Technology Development Co., Ltd.), acetonitrile (chromatographically pure, Fisher Company, USA), methanol (chromatographically pure, Fisher Company, USA), new green Acid (Chengdu Puruifa Technology Development Co., Ltd., batch number: 13112712, purity ≥98%), chlorogenic acid (China Food and Drug Testing Institute, batch number: 110753-201314, purity, 96.6%), cryptochlorogenic acid (Shanghai Source Leaf Biotechnology Co., Ltd., batch number: ZF0226BA14, purity ≥98%), isophoric acid ester A (Shanghai Yuanye Biotechnology Co., Ltd., batch number: YA0817HB14, purity ≥98%), 4,5-di-O- Caffeoylquinic acid (China Food and Drug Control Institute, batch number: 111894-201102, purity, 94.1%), saponin (HWIANALYTIK GMBH pharma solutions, batch number: HWI01112, purity, 91.7%), ammonium glycinate (Council of Europe) - EDQM, batch number: 1.1, purity ≥ 98%).
1.3试药:本发明中药组合物1.3 reagent: the traditional Chinese medicine composition of the invention
2.色谱条件2. Chromatographic conditions
2.1检测波长的选择2.1 Selection of detection wavelength
根据待测成分的对照品溶液的UV光谱图,选择327nm、250nm处的最大吸收峰作为检测波长,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸,250nm下检测槲皮苷和甘草酸,以尽量减少其它成分的干扰。According to the UV spectrum of the reference solution of the component to be tested, the maximum absorption peak at 327 nm and 250 nm was selected as the detection wavelength, and the new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4 were detected at 327 nm. , 5-di-O-caffeoylquinic acid, quercetin and glycyrrhizic acid were detected at 250 nm to minimize interference from other components.
2.2流动相的选择2.2 Choice of mobile phase
考察了不同比例的乙腈-甲醇-0.1%磷酸流动相系统,结果表明,按下表梯度洗脱所得色谱峰分离度好,基线平稳,待测色谱峰周围没有明显杂质干扰。The different ratios of acetonitrile-methanol-0.1% phosphoric acid mobile phase system were investigated. The results showed that the chromatographic peaks eluted by the gradient elution in the following table had good resolution and the baseline was stable. There was no obvious impurity interference around the chromatographic peaks to be tested.
梯度洗脱表Gradient elution table
Figure PCTCN2017075456-appb-000013
Figure PCTCN2017075456-appb-000013
Figure PCTCN2017075456-appb-000014
Figure PCTCN2017075456-appb-000014
2.3色谱条件的确定2.3 Determination of chromatographic conditions
以甲醇-乙腈-0.1%磷酸溶液为流动相,按上表进行梯度洗脱。检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱:ACQUITY
Figure PCTCN2017075456-appb-000015
HSS T3(1.8μm,2.1×100mm);柱温为35℃。
A methanol-acetonitrile-0.1% phosphoric acid solution was used as a mobile phase, and a gradient elution was carried out according to the above table. The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column: ACQUITY
Figure PCTCN2017075456-appb-000015
HSS T3 (1.8 μm, 2.1 x 100 mm); column temperature was 35 °C.
3.1提取溶剂的考察3.1 Investigation of extraction solvent
取本发明中药组合物适量,研细,取8份,每份0.5g,精密称定,置具塞锥形瓶中,每两份分别加入25mL甲醇、乙醇、50%甲醇和50%乙醇,超声处理(功率500W,频率40kHz)30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再分别加入25mL甲醇、乙醇、50%甲醇和50%乙醇,超声处理30分钟,过滤,用各提取溶剂洗涤药渣4次,每次5ml,合并洗涤液及两次滤液,蒸干,残渣用50%甲醇溶解并定容至25ml,作为供试品溶液。Take the appropriate amount of the traditional Chinese medicine composition of the present invention, and grind it, take 8 parts, 0.5g each, accurately weighed, place it in a conical flask, and add 25mL of methanol, ethanol, 50% methanol and 50% ethanol respectively. Ultrasonic treatment (power 500W, frequency 40kHz) for 30 minutes, filtered, the filtrate was obtained, the filter paper was added together with the residue into a stoppered conical flask, and then added with 25 mL of methanol, ethanol, 50% methanol and 50% ethanol, respectively, and sonicated for 30 minutes. The mixture was filtered, and the dregs were washed 4 times with 5 ml each time, and the washing liquid and the filtrate were combined, evaporated to dryness, and the residue was dissolved in 50% methanol and made up to 25 ml, as a test solution.
分别吸取供试品溶液2μL,注入液相色谱仪,测定供试品中待测成分的峰面积,结果见表1。2 μL of the test solution was separately taken and injected into a liquid chromatograph to measure the peak area of the component to be tested in the test sample. The results are shown in Table 1.
表1 不同提取溶剂考察的实验结果Table 1 Experimental results of different extraction solvents
Figure PCTCN2017075456-appb-000016
Figure PCTCN2017075456-appb-000016
实验结果表明:用50%乙醇作为提取溶剂时,待测成分的提取率最高。The experimental results show that when 50% ethanol is used as the extraction solvent, the extraction rate of the components to be tested is the highest.
3.2提取方法的考察3.2 Investigation of extraction methods
取本发明中药组合物适量,研细,取4份,每份0.5g,精密称定,置具塞锥形瓶中,分别加入50%乙醇25mL,每2份分别采用回流提取2小时和超声处理30分钟(2次)两种不同的提取方法提取,将提取液过滤,用50%乙醇洗涤药渣4次,每次5ml,将洗涤液与滤液合并,蒸干,残渣用50%甲醇溶解并定容至25ml,作为供试品溶液。分别精密吸取供试品溶液各2μL,注入液相色谱仪,测定供试品溶液中待测成分的峰面积,结果见表2。Take the appropriate amount of the traditional Chinese medicine composition of the present invention, and grind it, take 4 parts, 0.5g each, accurately weighed, place it in a conical flask, add 50mL of 50% ethanol, and extract 2 times each with reflux for 2 hours and ultrasound. The extract was extracted by two different extraction methods for 30 minutes (2 times), the extract was filtered, the dregs were washed 4 times with 50% ethanol, 5 ml each time, the washing liquid was combined with the filtrate, evaporated to dryness, and the residue was dissolved in 50% methanol. And to a volume of 25ml, as a test solution. 2 μL of each test solution was accurately aspirated and injected into a liquid chromatograph to determine the peak area of the component to be tested in the test solution. The results are shown in Table 2.
表2 不同提取方法考察的实验结果Table 2 Experimental results of different extraction methods
Figure PCTCN2017075456-appb-000017
Figure PCTCN2017075456-appb-000017
Figure PCTCN2017075456-appb-000018
Figure PCTCN2017075456-appb-000018
实验结果表明,回流提取比超声提取峰面积略高,均可作为本发明中药组合物的提取方式。The experimental results show that the reflux extraction is slightly higher than the ultrasonic extraction peak area, and can be used as the extraction method of the traditional Chinese medicine composition of the present invention.
3.3提取次数的考察3.3 Investigation of the number of extractions
分别考察超声提取1次、2次和3次,比较不同提取次数的提取效果,考察结果见下表3:The ultrasonic extraction was investigated once, twice and three times, and the extraction effects of different extraction times were compared. The results are shown in Table 3 below:
表3 不同提取次数的考察Table 3 Investigation of different extraction times
Figure PCTCN2017075456-appb-000019
Figure PCTCN2017075456-appb-000019
实验结果表明提取3次时,待测成分提取效率最高,但是提取3次时,提取效率仅比提取2次提高了1~2%,表明提取2次和提取3次所得结果差别不大。The experimental results show that the extraction efficiency of the components to be tested is the highest when extracted three times, but the extraction efficiency is only 1-2% higher than that of the extraction three times, which indicates that the results of extraction and extraction are not much different.
3.4供试品溶液制备方法的确定3.4 Determination of the preparation method of the test solution
取本发明中药组合物适量,研细,取0.5g,精密称定,置具塞锥形瓶中,加50%乙醇25mL,超声处理(功率500W,频率40kHz)30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加50%乙醇25mL,超声处理30分钟,过滤,用50%乙醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得。Take the proper amount of the traditional Chinese medicine composition of the present invention, grind it, take 0.5g, accurately weigh it, place it in a conical flask, add 25mL of 50% ethanol, sonicate (power 500W, frequency 40kHz) for 30 minutes, filter, and obtain the filtrate. Add the filter paper together with the residue into a stoppered conical flask, add 25mL of 50% ethanol, sonicate for 30 minutes, filter, wash the dregs with 50% ethanol 4 times, each time 5mL, combine the filtrate and washing solution twice, steam Dry, the residue was dissolved in 50% methanol and made up to 25 mL.
对照品溶液的制备Preparation of reference solution
取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg 4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得(甘草酸重量=甘草酸铵重量/1.0207)。Take the appropriate amount of new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate, accurately weighed, Add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg 4,5-di-O-caffeoyl A mixed solution of n-acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate was obtained (weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207).
线性关系考察Linear relationship
分别精密称取15.56mg新绿原酸与15.66mg隐绿原酸置于10ml容量瓶中,用50%甲醇溶解并稀释至刻度作为对照品母液1;分别精密称取15.35mg绿原酸与11.24mg异连翘酯苷A置于10ml容量瓶中,用50%甲醇溶解并稀释至刻度作为对照品母液2;分别精密称取15.88mg4,5-二-O-咖啡酰奎宁酸与12.24mg槲皮苷对照品置于10ml的容量瓶中用50%甲醇溶解并稀释至刻度作为对照品母液3,分别精密称取10.69mg甘草酸铵对照品置于10ml的容量瓶中用50%甲醇溶解并稀释至刻度作为对照品母液4,再分别从对照品母液1、2、3、4中精密吸取1ml、3ml、1ml、2ml置于10ml容量瓶中,用50%甲醇定容至刻度作为对照品的储备液,再分别从储备液中精密吸取0.1、0.2、0.5、1、2、4ml置于10ml的容量瓶中,用50%的甲醇定容至刻度,得到不同质量浓度的系列对照品溶液。Weigh accurately 15.56mg of new chlorogenic acid and 15.66mg of cryptochlorogenic acid in a 10ml volumetric flask, dissolve it with 50% methanol and dilute to the scale as the reference mother liquor 1; accurately weigh 15.35mg chlorogenic acid and 11.24mg respectively. The isophoraside A was placed in a 10 ml volumetric flask, dissolved in 50% methanol and diluted to the mark as the reference mother liquor 2; respectively, 15.88 mg of 4,5-di-O-caffeoylquinic acid and 12.24 mg of cesium were accurately weighed respectively. The lycopene reference substance was placed in a 10 ml volumetric flask and dissolved in 50% methanol and diluted to the scale as the reference mother liquid 3, respectively. 10.69 mg of ammonium glycyrrhizinate reference substance was accurately weighed and placed in a 10 ml volumetric flask and dissolved in 50% methanol. Dilute to the scale as the reference mother liquor 4, and then accurately extract 1ml, 3ml, 1ml, 2ml from the reference mother liquor 1, 2, 3, 4 into a 10ml volumetric flask, and dilute to the scale with 50% methanol as a reference. The stock solution is then accurately extracted from the stock solution by 0.1, 0.2, 0.5, 1, 2, 4 ml in a 10 ml volumetric flask, and the volume is adjusted to the mark with 50% methanol to obtain a series of reference solutions of different mass concentrations. .
分别精密吸取含新绿原酸1.56μg/mL、3.12μg/mL、7.78μg/mL、15.56μg/mL、31.12μg/mL和62.24μg/mL,含绿原酸4.45μg/mL、8.90μg/mL、22.24μg/mL、44.48μg/mL、88.97μg/mL和177.94μg/mL,含隐绿原酸1.57μg/mL、 3.13μg/mL、7.83μg/mL、15.66μg/mL、31.32μg/mL、62.64μg/mL,含异连翘酯苷A3.37μg/mL、6.74μg/mL、16.86μg/mL、33.72μg/mL、67.44μg/mL、134.88μg/mL,含4,5-二-O-咖啡酰奎宁酸1.49μg/mL、2.99μg/mL、7.47μg/mL、14.94μg/mL、29.89μg/mL、59.77μg/mL,含槲皮苷1.12μg/mL、2.24μg/mL、5.61μg/mL、11.22μg/mL、22.45μg/mL、44.90μg/mL,含甘草酸2.09μg/mL、4.19μg/mL、10.47μg/mL、20.95μg/mL、41.89μg/mL、83.79μg/mL的系列对照品溶液各2μL,分别注入超高效液相色谱仪,按拟定的色谱条件测定,以对照品质量浓度为横坐标,峰面积为纵坐标,绘制标准曲线,得新绿原酸回归方程:y=20628x-1699.7(R2=0.9999),结果表明新绿原酸在1.56μg/mL~62.24μg/mL范围内线性良好;绿原酸回归方程:y=19778x+8305.9(R2=0.9999),结果表明绿原酸在4.45μg/mL~177.94μg/mL范围内线性良好;隐绿原酸回归方程:y=14319x-933.94(R2=0.9999),结果表明隐绿原酸在1.57μg/mL~62.64μg/mL范围内线性良好;异连翘酯苷A回归方程:y=7951.8x-2304.5(R2=0.9999),结果表明异连翘酯苷A在3.37μg/mL~134.88μg/mL范围内线性良好;4,5-二-O-咖啡酰奎宁酸回归方程为:y=20148x-2422.8(R2=0.9999),结果表明4,5-二-O-咖啡酰奎宁酸在1.49μg/mL~59.77μg/mL范围内线性良好;槲皮苷回归方程:y=13288x-3121.6(R2=0.9999),结果表明槲皮苷在1.12μg/mL~44.90μg/mL范围内线性良好;甘草酸回归方程为:y=2731.3x+810.9(R2=0.9999),结果表明甘草酸在2.09μg/mL~83.79μg/mL范围内线性良好。实验结果见表4-7。Precision extraction of fresh chlorogenic acid 1.56μg/mL, 3.12μg/mL, 7.78μg/mL, 15.56μg/mL, 31.12μg/mL and 62.24μg/mL, containing chlorogenic acid 4.45μg/mL, 8.90μg/mL 22.24 μg/mL, 44.48 μg/mL, 88.97 μg/mL, and 177.94 μg/mL, containing cryptochlorogenic acid 1.57 μg/mL, 3.13 μg/mL, 7.83 μg/mL, 15.66 μg/mL, 31.32 μg/mL 62.64 μg/mL, containing forathiaside A3.37 μg/mL, 6.74 μg/mL, 16.86 μg/mL, 33.72 μg/mL, 67.44 μg/mL, 134.88 μg/mL, containing 4,5-di- O-caffeoyl quinic acid 1.49 μg/mL, 2.99 μg/mL, 7.47 μg/mL, 14.94 μg/mL, 29.89 μg/mL, 59.77 μg/mL, containing quercetin 1.12 μg/mL, 2.24 μg/mL 5.61 μg/mL, 11.22 μg/mL, 22.45 μg/mL, 44.90 μg/mL, containing glycyrrhizic acid 2.09 μg/mL, 4.19 μg/mL, 10.47 μg/mL, 20.95 μg/mL, 41.89 μg/mL, 83.79 2 μL of each of the μg/mL series of reference solutions were injected into the ultra-high performance liquid chromatograph, and determined according to the proposed chromatographic conditions. The mass concentration of the reference substance was plotted on the abscissa and the peak area was plotted on the ordinate. The standard curve was drawn to obtain the new chlorogenic acid. Regression equation: y=20628x-1699.7 (R 2 =0.9999), the results show that the new chlorogenic acid is in the range of 1.56μg/mL~6 The linearity was good in the range of 2.24μg/mL; the regression equation of chlorogenic acid: y=19778x+8305.9 (R 2 =0.9999), the results showed that the chlorogenic acid was linear in the range of 4.45μg/mL~177.94μg/mL; The acid regression equation: y=14319x-933.94 (R 2 =0.9999), the results showed that the cryptochlorogenic acid was linear in the range of 1.57μg/mL~62.64μg/mL; the regression equation of the forsythin A: y=7951.8x -2304.5 (R 2 =0.9999), the results showed that the forsythiaside A was linearly good in the range of 3.37 μg/mL to 134.88 μg/mL; the regression equation of 4,5-di-O-caffeoylquinic acid was: y =20148x-2422.8 (R 2 =0.9999), the results showed that 4,5-di-O-caffeoylquinic acid was linear in the range of 1.49 μg / mL ~ 59.77 μg / mL; ecdysin regression equation: y = 13288x -3121.6 (R 2 =0.9999), the results showed that quercetin was linearly good in the range of 1.12 μg/mL to 44.90 μg/mL; the regression equation of glycyrrhizic acid was: y=2731.3x+810.9 (R 2 =0.9999), the results showed The glycyrrhizic acid has a good linearity in the range of 2.09 μg/mL to 83.79 μg/mL. The experimental results are shown in Table 4-7.
表4 新绿原酸和绿原酸对照品溶液的线性关系考察Table 4 Linear relationship between new chlorogenic acid and chlorogenic acid reference solution
Figure PCTCN2017075456-appb-000020
Figure PCTCN2017075456-appb-000020
表5 隐绿原酸和异连翘酯苷A对照品溶液的线性关系考察Table 5 Linear relationship between cryptochlorogenic acid and isoprehtilin A reference solution
Figure PCTCN2017075456-appb-000021
Figure PCTCN2017075456-appb-000021
表6 4,5-二-O-咖啡酰奎宁酸和槲皮苷对照品溶液的线性关系考察Table 6 Linear relationship between 4,5-di-O-caffeoylquinic acid and quercetin reference solution
Figure PCTCN2017075456-appb-000022
Figure PCTCN2017075456-appb-000022
Figure PCTCN2017075456-appb-000023
Figure PCTCN2017075456-appb-000023
表7 甘草酸对照品溶液的线性关系考察Table 7 Linear relationship between glycyrrhizic acid reference solution
Figure PCTCN2017075456-appb-000024
Figure PCTCN2017075456-appb-000024
5.检测限和定量限的确定5. Determination of detection limits and limit of quantitation
将待测成分的混合对照品溶液稀释成一系列浓度的溶液,进行UPLC检测,记录信号强度与噪音强度的比值,将信号强度和噪音强度之比等于3时的浓度作为检测限,将信号强度和噪音强度之比等于10时的浓度作为定量限。最终确定新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、槲皮苷、4,5-二-O-咖啡酰奎宁酸、甘草酸的检测限分别为0.051μg/mL、0.049μg/mL、0.052μg/mL、0.111μg/mL、0.037μg/mL、0.049μg/mL和2.095μg/mL;定量限分别为0.156μg/mL、0.147μg/mL、0.157μg/mL、0.337μg/mL、0.112μg/mL、0.149μg/mL和6.200μg/mL。Dilute the mixed reference solution of the component to be tested into a series of solutions, perform UPLC detection, record the ratio of signal intensity to noise intensity, and use the concentration of signal intensity and noise intensity equal to 3 as the detection limit, and the signal intensity and The concentration at which the noise intensity ratio is equal to 10 is taken as the limit of quantification. The detection limits of new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, quercetin, 4,5-di-O-caffeoylquinic acid and glycyrrhizic acid were determined to be 0.051 μg/ mL, 0.049 μg/mL, 0.052 μg/mL, 0.111 μg/mL, 0.037 μg/mL, 0.049 μg/mL, and 2.095 μg/mL; the limits of quantification were 0.156 μg/mL, 0.147 μg/mL, and 0.157 μg/mL, respectively. 0.337 μg/mL, 0.112 μg/mL, 0.149 μg/mL, and 6.200 μg/mL.
精密度考察Precision inspection
取对照品溶液(浓度为:新绿原酸31.12μg/mL;绿原酸88.97μg/mL;隐绿原酸31.32μg/mL;异连翘酯苷A67.44μg/mL;4,5-二-O-咖啡酰奎宁酸29.89μg/mL;槲皮苷22.45μg/mL;甘草酸41.89μg/mL)连续进样6次,记录峰面积,计算各色谱峰峰面积的相对标准偏差(RSD)来考察仪器精密度,结果见表8。Take the reference solution (concentration: new chlorogenic acid 31.12μg/mL; chlorogenic acid 88.97μg/mL; cryptogenic chlorogenic acid 31.32μg/mL; avermectin A67.44μg/mL; 4,5-di- O-caffeoylquinic acid 29.89μg/mL; quercetin 22.45μg/mL; glycyrrhizic acid 41.89μg/mL) was continuously injected 6 times, the peak area was recorded, and the relative standard deviation (RSD) of each chromatographic peak area was calculated. To examine the precision of the instrument, the results are shown in Table 8.
表8 精密度考察Table 8 Precision inspection
Figure PCTCN2017075456-appb-000025
Figure PCTCN2017075456-appb-000025
Figure PCTCN2017075456-appb-000026
Figure PCTCN2017075456-appb-000026
待测成分峰面积的RSD均小于2%,表明仪器精密度良好。The RSD of the peak area of the component to be tested is less than 2%, indicating that the precision of the instrument is good.
重复性考察Repetitive investigation
取同一批本发明中药组合物适量,分别按“供试品溶液的制备”中取样量的80%、100%、120%取样,每个取样量各制备3份,依法测定。根据每一份所含待测成分的含量,计算RSD,结果见表9。Taking the same batch of the traditional Chinese medicine composition of the present invention, the samples were sampled according to the sample amount of "preparation of the test solution" at 80%, 100%, and 120%, and each sample was prepared in three portions, and determined according to law. The RSD is calculated based on the content of each component to be tested, and the results are shown in Table 9.
表9 重复性考察实验结果Table 9 Repeatability test results
Figure PCTCN2017075456-appb-000027
Figure PCTCN2017075456-appb-000027
由测定结果可知,待测成分含量的RSD均小于3%,表明该方法重复性良好。It can be seen from the measurement results that the RSD of the content of the component to be tested is less than 3%, indicating that the method has good repeatability.
稳定性考察Stability investigation
精密吸取供试品溶液,分别于室温放置0、2、4、6、8和12小时时进样一次,分别记录待测成分的峰面积,并计算峰面积的RSD,对稳定性进行考察,测定结果见表10。The test solution was accurately taken and injected at room temperature for 0, 2, 4, 6, 8 and 12 hours, respectively. The peak area of the component to be tested was recorded, and the RSD of the peak area was calculated. The stability was investigated. The measurement results are shown in Table 10.
表10 稳定性实验结果Table 10 Stability test results
Figure PCTCN2017075456-appb-000028
Figure PCTCN2017075456-appb-000028
Figure PCTCN2017075456-appb-000029
Figure PCTCN2017075456-appb-000029
由测定结果可知,待测成分的峰面积的RSD均在3%以内,表明供试品溶液12h内稳定。It can be seen from the measurement results that the RSD of the peak area of the component to be tested is within 3%, indicating that the test solution is stable within 12 hours.
加样回收率考察Sample recovery rate
按取样量0.5g的二分之一,即0.25g,称取本品,精密称定,平行9份,分为3组,分别加入低、中、高3种质量浓度的待测成分对照品溶液,按“供试品溶液制备方法”制备待测溶液,依法测定,对回收率试验进行考察。结果见表11-17。According to the sampling amount of 0.5g of one-half, that is, 0.25g, weigh the product, accurately weighed, paralleled 9 parts, divided into 3 groups, respectively added low, medium and high three kinds of mass concentration of the reference substance to be tested The solution is prepared according to the "preparation method of the test solution", and is determined according to law, and the recovery rate test is investigated. The results are shown in Table 11-17.
表11 新绿原酸加样回收率考察Table 11 Investigation on the recovery rate of new chlorogenic acid
Figure PCTCN2017075456-appb-000030
Figure PCTCN2017075456-appb-000030
从表11测定结果可知,新绿原酸的平均加样回收率为99.44%,RSD为2.71%,符合要求。From the results of Table 11, it was found that the average recovery of new chlorogenic acid was 99.44%, and the RSD was 2.71%, which was in compliance with the requirements.
表12 绿原酸加样回收率考察Table 12 Investigation on recovery rate of chlorogenic acid
Figure PCTCN2017075456-appb-000031
Figure PCTCN2017075456-appb-000031
从表12测定结果可知,绿原酸的平均加样回收率为99.82%,RSD为2.67%,符合要求。From the results of Table 12, it was found that the average recovery of chlorogenic acid was 99.82%, and the RSD was 2.67%, which was in compliance with the requirements.
表13 隐绿原酸加样回收率考察Table 13 Investigation on the recovery rate of cryptochloric acid
Figure PCTCN2017075456-appb-000032
Figure PCTCN2017075456-appb-000032
Figure PCTCN2017075456-appb-000033
Figure PCTCN2017075456-appb-000033
从表13测定结果可知,隐绿原酸的平均加样回收率为97.61%,RSD为1.64%,符合要求。From the measurement results in Table 13, it was found that the average sample recovery rate of cryptochlorogenic acid was 97.61%, and the RSD was 1.64%, which was in compliance with the requirements.
表14 异连翘酯苷A加样回收率考察Table 14 Investigation on the recovery rate of isophoric acid ester A
Figure PCTCN2017075456-appb-000034
Figure PCTCN2017075456-appb-000034
从表14测定结果可知,异连翘酯苷A的平均加样回收率为97.17%,RSD为1.63%,符合要求。From the results of the measurement in Table 14, it was found that the average sample recovery rate of the forsythiaside A was 97.17%, and the RSD was 1.63%, which was in compliance with the requirements.
表15 槲皮苷加样回收率考察Table 15 Investigation of the recovery rate of quercetin
Figure PCTCN2017075456-appb-000035
Figure PCTCN2017075456-appb-000035
Figure PCTCN2017075456-appb-000036
Figure PCTCN2017075456-appb-000036
从表15测定结果可知,槲皮苷的平均加样回收率为99.19%,RSD为2.89%,符合要求。From the results of Table 15, it was found that the average recovery of quercetin was 99.19%, and the RSD was 2.89%, which was in compliance with the requirements.
表16 4,5-二-O-咖啡酰奎宁酸加样回收率考察Table 16 Investigation of the recovery rate of 4,5-di-O-caffeoylquinic acid
Figure PCTCN2017075456-appb-000037
Figure PCTCN2017075456-appb-000037
从表16测定结果可知,4,5-二-O-咖啡酰奎宁酸的平均加样回收率为100.46%,RSD为1.92%,符合要求。From the results of Table 16, it was found that the average recovery of 4,5-di-O-caffeoylquinic acid was 100.46%, and the RSD was 1.92%, which was in compliance with the requirements.
表17 甘草酸加样回收率考察Table 17 Investigation on the recovery rate of glycyrrhizic acid
Figure PCTCN2017075456-appb-000038
Figure PCTCN2017075456-appb-000038
从表17测定结果可知,甘草酸的平均加样回收率为100.32%,RSD为0.97%,符合要求。From the results of Table 17, it was found that the average recovery of glycyrrhizic acid was 100.32%, and the RSD was 0.97%, which was in compliance with the requirements.
系统耐用性试验System durability test
10.1流速变化对多成分含量测定的影响10.1 Effect of flow rate change on determination of multi-component content
取供试品溶液,固定其他色谱条件,分别在流速为0.25mL/min、0.3mL/min和0.35mL/min进行测定,并按各个成分的对照品做对照,分别计算待测成分的含量,比较流速变化对测定结果的影响,结果见表18。The test solution was taken, and other chromatographic conditions were fixed, and the flow rates were 0.25 mL/min, 0.3 mL/min, and 0.35 mL/min, respectively, and the contents of the components to be tested were calculated according to the reference materials of the respective components. The effect of the change in flow rate on the measurement results was compared. The results are shown in Table 18.
表18 流速变化对待测成分含量的影响Table 18 Effect of flow rate changes on the content of the components to be tested
Figure PCTCN2017075456-appb-000039
Figure PCTCN2017075456-appb-000039
Figure PCTCN2017075456-appb-000040
Figure PCTCN2017075456-appb-000040
由上述结果可知,流速变化后,隐绿原酸,槲皮苷和甘草酸的RSD大于3%,表明流速的微小变化,对样品中这3个成分的影响较大。From the above results, the RSD of cryptochlorogenic acid, quercetin and glycyrrhizic acid was more than 3% after the flow rate was changed, indicating that the flow velocity was slightly changed, and the influence on the three components in the sample was large.
10.2波长变化对待测成分的含量测定的影响10.2 Effect of wavelength change on the determination of the content of the component to be tested
取供试品溶液,固定其他色谱条件,分别在波长322、245nm,327、250nm和332、255nm进行测定,并以各个待测成分对照品做对照,分别计算待测成分的含量,比较波长变化对测定结果的影响。结果见表19。The test solution was taken and other chromatographic conditions were fixed and measured at wavelengths of 322, 245 nm, 327, 250 nm, and 332, 255 nm, respectively, and the reference substance of each component to be tested was used as a control to calculate the content of the component to be tested, and to compare wavelength changes. The effect on the measurement results. The results are shown in Table 19.
表19 波长变化对待测成分含量的影响Table 19 Effect of wavelength change on the content of the component to be tested
Figure PCTCN2017075456-appb-000041
Figure PCTCN2017075456-appb-000041
由上述结果可知,波长变化后,隐绿原酸,槲皮苷和4,5-二-O咖啡酰奎宁酸含量测定结果的RSD值大于3%,表明波长的微小变化,对样品中这3个成分含量测定结果影响较大。From the above results, it can be seen that after the wavelength change, the RSD value of the measurement results of cryptochlorogenic acid, quercetin and 4,5-di-Ocaffeoylquinic acid is more than 3%, indicating a slight change in wavelength, which is in the sample. The results of the determination of the three components have a great influence.
10.3柱温变化对待测成分的含量测定的影响10.3 Effect of column temperature change on the determination of the content of the components to be tested
取供试品溶液,固定其他色谱条件,分别在柱温30℃、35℃和40℃进行测定,并以各个待测成分的对照品做对照,分别计算待测成分的含量,比较柱温变化对测定结果的影响。Take the test solution, fix other chromatographic conditions, measure at column temperature 30 °C, 35 °C and 40 °C, respectively, and compare the reference components of each component to be tested, calculate the content of the component to be tested, and compare the column temperature changes. The effect on the measurement results.
表20 柱温变化对待测成分含量的影响Table 20 Effect of column temperature change on the content of components to be tested
Figure PCTCN2017075456-appb-000042
Figure PCTCN2017075456-appb-000042
Figure PCTCN2017075456-appb-000043
Figure PCTCN2017075456-appb-000043
由上述结果可知,柱温变化后,隐绿原酸,4,5-二-O咖啡酰奎宁酸,甘草酸含量测定结果的RSD值均大于3%,表明柱温的微小变化,对样品中这3个成分的含量测定结果影响较大。It can be seen from the above results that after the change of column temperature, the RSD values of chlorogenic acid, 4,5-di-O-caffeoylquinic acid and glycyrrhizic acid content are all greater than 3%, indicating that the column temperature is slightly changed to the sample. The content determination results of these three components have a great influence.
10.4不同色谱柱对待测成分的含量测定的影响10.4 Effect of different chromatographic columns on the determination of the components to be tested
取供试品溶液,固定其他色谱条件,分别用ACQUITY
Figure PCTCN2017075456-appb-000044
CSHTMC18(1.7μm,2.1×100mm)、ACQUITY
Figure PCTCN2017075456-appb-000045
BEHC18(1.7μm,2.1×100mm)、ACQUITY
Figure PCTCN2017075456-appb-000046
BEH shieldRP 18(1.7μm,2.1×100mm)和ACQUITY
Figure PCTCN2017075456-appb-000047
HSS T3(1.8μm,2.1×100mm)等四种不同的色谱柱进行测试,比较不同色谱柱对待测成分峰形以及分离度的影响。结果表明均可用于本发明中药组合物四种成分的含量测定,使用HSS T3柱时,待测成分峰形以及分离度最好。
Take the test solution, fix other chromatographic conditions, use ACQUITY
Figure PCTCN2017075456-appb-000044
CSH TM C 18 (1.7μm, 2.1×100mm), ACQUITY
Figure PCTCN2017075456-appb-000045
BEHC 18 (1.7μm, 2.1×100mm), ACQUITY
Figure PCTCN2017075456-appb-000046
BEH shieldRP 18 (1.7μm, 2.1×100mm) and ACQUITY
Figure PCTCN2017075456-appb-000047
Four different columns, such as HSS T3 (1.8μm, 2.1×100mm), were tested to compare the effects of different chromatographic columns on the peak shape and resolution of the components to be tested. The results show that the content of the four components of the traditional Chinese medicine composition of the present invention can be used. When the HSS T3 column is used, the peak shape and the resolution of the component to be tested are the best.
中间精密度Intermediate precision
按照已确定的含量测定方法,分别由不同的分析人员在不同的时间、分别用两台不同的UPLC仪器测定同一批次本发明中药组合物待测成分的含量,每次试验平行操作3份供试品,对中间精密度进行考察。结果见表21-25。According to the determined content determination method, the content of the same batch of the components of the traditional Chinese medicine composition of the present invention is determined by different analysts at different times and using two different UPLC instruments, and each test is operated in parallel for 3 times. Test the sample and examine the intermediate precision. The results are shown in Table 21-25.
表21 分析人员甲用UPLC(1)测定待测成分的含量Table 21 Analyst A uses UPLC (1) to determine the content of the component to be tested
Figure PCTCN2017075456-appb-000048
Figure PCTCN2017075456-appb-000048
表22 分析人员乙用UPLC(1)测定待测成分的含量Table 22 Analyst B uses UPLC (1) to determine the content of the component to be tested
Figure PCTCN2017075456-appb-000049
Figure PCTCN2017075456-appb-000049
表23 分析人员甲用UPLC(2)测定待测成分的含量Table 23 Analyst A uses UPLC (2) to determine the content of the component to be tested
Figure PCTCN2017075456-appb-000050
Figure PCTCN2017075456-appb-000050
Figure PCTCN2017075456-appb-000051
Figure PCTCN2017075456-appb-000051
表24 分析人员乙用UPLC(2)测定待测成分的含量Table 24 Analyst B uses UPLC (2) to determine the content of the component to be tested
Figure PCTCN2017075456-appb-000052
Figure PCTCN2017075456-appb-000052
表25 中间精密度考察结果Table 25 Intermediate precision inspection results
Figure PCTCN2017075456-appb-000053
Figure PCTCN2017075456-appb-000053
由上述试验结果可知,由不同人员在不同时间、不同仪器测定同一批次本发明中药组合物待测成分含量的RSD值均小于5%,表明该方法中间精密度良好。It can be seen from the above test results that the RSD values of the components of the traditional Chinese medicine composition of the present invention are less than 5% by different people at different times and different instruments, indicating that the precision of the method is good.
三批本发明中药组合物七种成分含量测定Determination of seven components in three batches of traditional Chinese medicine composition of the invention
用所制定的含量测定方法,对3批本发明中药组合物待测成分的含量进行了测定,结果见表26。The content of the components to be tested of the three batches of the traditional Chinese medicine composition of the present invention was measured by the determined content determination method, and the results are shown in Table 26.
表26 3批中药组合物胶囊中间体中待测成分的含量测定结果Table 26 Determination of the content of the components to be tested in the capsule intermediate of the 3 batches of traditional Chinese medicine composition
Figure PCTCN2017075456-appb-000054
Figure PCTCN2017075456-appb-000054
Figure PCTCN2017075456-appb-000055
Figure PCTCN2017075456-appb-000055
本发明建立了本发明中药组合物的四种药材中七种成分的含量测定方法,通过方法学研究结果表明,本方法测定连翘、金银花、鱼腥草和甘草四种药材中的有效成分具有良好的准确度、精密度、稳定性和重复性,可以有效的控制该中药组合物的质量及安全。The invention establishes a method for determining the content of seven components in the four herbs of the traditional Chinese medicine composition of the invention, and the methodological research results show that the method has the active ingredients in the four herbs of forsythia, honeysuckle, houttuynia and licorice. Good accuracy, precision, stability and repeatability can effectively control the quality and safety of the traditional Chinese medicine composition.
附图说明DRAWINGS
图1:327nm下对照品色谱图,其中1为新绿原酸,2为绿原酸,3为隐绿原酸,4为异连翘酯苷A,5为4,5-二-O-咖啡酰奎宁酸Figure 1: Chromatogram of the reference at 327nm, where 1 is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid A, and 5 is 4,5-di-O-coffee. Acyl quinic acid
图2:供试品溶液在327nm下色谱图Figure 2: Chromatogram of the test solution at 327 nm
图3:250nm下对照品色谱图,其中6为槲皮苷,7为甘草酸Figure 3: Chromatogram of the reference at 250 nm, where 6 is quercetin and 7 is glycyrrhizic acid
图4:供试品溶液在250nm下色谱图Figure 4: Chromatogram of the test solution at 250 nm
图5:实施例1色谱图谱:A图为327nm下对照品色谱图,其中1为新绿原酸,2为绿原酸,3为隐绿原酸,4为异连翘酯苷A,5为4,5-二-O-咖啡酰奎宁酸;B图为327nm下供试品色谱图;C图为250nm下对照品色谱图,其中6为槲皮苷,7为甘草酸;D图为250nm下供试品色谱图。Figure 5: Chromatogram of Example 1: A is a chromatogram of the reference at 327 nm, where 1 is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid A, 5 is 4,5-di-O-caffeoylquinic acid; B picture is the chromatogram of the test sample at 327nm; C picture is the chromatogram of the reference substance at 250nm, of which 6 is quercetin, 7 is glycyrrhizic acid; Chromatogram of the test sample at 250 nm.
图6:实施例2色谱图谱:A图为327nm下对照品色谱图,其中1为新绿原酸,2为绿原酸,3为隐绿原酸,4为异连翘酯苷A,5为4,5-二-O-咖啡酰奎宁酸;B图为327nm下供试品色谱图;C图为250nm下对照品色谱图,其中6为槲皮苷,7为甘草酸;D图为250nm下供试品色谱图。Figure 6: Chromatogram of Example 2: Figure A is a chromatogram of the reference substance at 327 nm, where 1 is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid A, 5 is 4,5-di-O-caffeoylquinic acid; B picture is the chromatogram of the test sample at 327nm; C picture is the chromatogram of the reference substance at 250nm, of which 6 is quercetin, 7 is glycyrrhizic acid; Chromatogram of the test sample at 250 nm.
图7:实施例3色谱图谱:A图为327nm下对照品色谱图,其中1为新绿原酸,2为绿原酸,3为隐绿原酸,4为异连翘酯苷A,5为4,5-二-O-咖啡酰奎宁酸;B图为327nm下供试品色谱图;C图为250nm下对照品色谱图,其中6为槲皮苷,7为甘草酸;D图为250nm下供试品色谱图。Figure 7: Chromatogram of Example 3: Figure A is a chromatogram of the reference substance at 327 nm, where 1 is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid A, 5 is 4,5-di-O-caffeoylquinic acid; B picture is the chromatogram of the test sample at 327nm; C picture is the chromatogram of the reference substance at 250nm, of which 6 is quercetin, 7 is glycyrrhizic acid; Chromatogram of the test sample at 250 nm.
图8:实施例4色谱图谱:A图为327nm下对照品色谱图,其中1为新绿原酸,2为绿原酸,3为隐绿原酸,4为异连翘酯苷A,5为4,5-二-O-咖啡酰奎宁酸;B图为327nm下供试品色谱图;C图为250nm下对照品色谱图,其中6为槲皮苷,7为甘草酸;D图为250nm下供试品色谱图。Figure 8: Chromatogram of Example 4: Figure A is a chromatogram of the reference substance at 327 nm, where 1 is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid A, 5 is 4,5-di-O-caffeoylquinic acid; B picture is the chromatogram of the test sample at 327nm; C picture is the chromatogram of the reference substance at 250nm, of which 6 is quercetin, 7 is glycyrrhizic acid; Chromatogram of the test sample at 250 nm.
具体实施方式detailed description
实施例1Example 1
按比例称取:连翘200g、金银花300g、板蓝根200g、大黄40g、广藿香60g、绵马贯众300g、红景天100g、薄荷脑9g、麻黄60g、苦杏仁100g、鱼腥草200g、甘草100g、石膏200g,按照以下工艺提取:Weighed according to the ratio: Forsythia 200g, Honeysuckle 300g, Radix Isatidis 200g, Rhubarb 40g, Patchouli 60g, Mianma Guanzhong 300g, Rhodiola 100g, Menthol 9g, Ephedra 60g, Bitter Almond 100g, Houttuynia 200g, Licorice 100g, gypsum 200g, extracted according to the following process:
(1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
(2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
(3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
(4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
(5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
(6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒; (6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
(7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,装胶囊,即得。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed, and capsules are obtained.
含量测定方法:Method of determination:
供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加50%乙醇25mL,超声提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加50%乙醇25mL,超声处理30分钟,过滤,用50%乙醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 50mL ethanol, 25mL, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, The filtrate was obtained, and the filter paper was added together with the residue into a stoppered conical flask, and 25 mL of 50% ethanol was added thereto, sonicated for 30 minutes, filtered, and the dregs were washed 4 times with 50% ethanol, 5 mL each time, and the filtrate and washing were combined twice. The liquid is evaporated to dryness, and the residue is dissolved in 50% methanol and made up to 25 mL, which is obtained;
对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg 4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg 4,5-two a mixed solution of -O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
Figure PCTCN2017075456-appb-000056
Figure PCTCN2017075456-appb-000056
检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱:ACQUITY
Figure PCTCN2017075456-appb-000057
HSS T3(1.8μm,2.1×100mm);柱温为35℃;
The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column: ACQUITY
Figure PCTCN2017075456-appb-000057
HSS T3 (1.8 μm, 2.1 × 100 mm); column temperature is 35 ° C;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
结论:结果令人满意,可以用于控制该中药组合物的质量。Conclusion: The results are satisfactory and can be used to control the quality of the traditional Chinese medicine composition.
实施例2Example 2
按比例称取:连翘300g、金银花200g、板蓝根300g、大黄60g、广藿香100g、绵马贯众200g、红景天60g、薄荷脑5g、麻黄100g、苦杏仁60g、鱼腥草300g、甘草60g、石膏300g,按照以下工艺提取:Weighed in proportion: Forsythia 300g, Honeysuckle 200g, Radix Isatidis 300g, Rhubarb 60g, Patchouli 100g, Mianma Guanzhong 200g, Rhodiola 60g, Menthol 5g, Ephedra 100g, Bitter Almond 60g, Houttuynia 300g, Glycyrrhiza 60g, gypsum 300g, extracted according to the following process:
(1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
(2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
(3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
(4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
(5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
(6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
(7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,压片,即得。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed and tableted.
含量测定方法:Method of determination:
供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加50%甲醇25mL,超声提取,功率 500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加50%甲醇25mL,超声处理30分钟,过滤,用50%甲醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 50% methanol 25mL, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, obtain the filtrate, add the filter paper together with the residue into the conical flask, add 50mL methanol 25mL, sonicate for 30 minutes, filter, wash the dregs with 50% methanol 4 times 5mL each time, the filtrate and washing solution were combined twice, evaporated to dryness, and the residue was dissolved in 50% methanol and made up to 25 mL, which was obtained;
对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg 4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg 4,5-two a mixed solution of -O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
Figure PCTCN2017075456-appb-000058
Figure PCTCN2017075456-appb-000058
检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为ACQUITY
Figure PCTCN2017075456-appb-000059
CSHTMC18
The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column is ACQUITY
Figure PCTCN2017075456-appb-000059
CSH TM C 18 ;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
结论:结果令人满意可以用于控制该中药组合物的质量。Conclusion: Satisfactory results can be used to control the quality of the Chinese herbal composition.
实施例3Example 3
原料药配方为:连翘278g、金银花294g、板蓝根285g、大黄55g、广藿香95g、绵马贯众290g、红景天87g、薄荷脑8.5g、麻黄88g、苦杏仁80g、鱼腥草284g、甘草95g、石膏277g,按照以下工艺提取:The raw material formula is: Forsythia 278g, Honeysuckle 294g, Radix Isatidis 285g, Rhubarb 55g, Patchouli 95g, Mianma Guanzhong 290g, Rhodiola 87g, Menthol 8.5g, Ephedra 88g, Bitter Almond 80g, Houttuynia 284g , licorice 95g, gypsum 277g, according to the following process:
(1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
(2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
(3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
(4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
(5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
(6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
(7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,装袋,即得。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed, and the bag is obtained.
含量测定方法:Method of determination:
供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加甲醇25mL,回流提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加甲醇25mL,超声处理30分钟,过滤,用甲醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得; Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of methanol, reflux extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, and obtain filtrate Add the filter paper together with the residue into a stoppered conical flask, add 25mL of methanol, sonicate for 30 minutes, filter, wash the dregs with methanol 4 times, each time 5mL, combine the filtrate and washing solution twice, evaporate and dry, residue Dissolve with 50% methanol and dilute to 25mL, that is;
对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg 4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg 4,5-two a mixed solution of -O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
Figure PCTCN2017075456-appb-000060
Figure PCTCN2017075456-appb-000060
检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为ACQUITY
Figure PCTCN2017075456-appb-000061
BEH C18
The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column is ACQUITY
Figure PCTCN2017075456-appb-000061
BEH C 18 ;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
结果:结果令人满意可以用于控制该中药组合物的质量。Results: Satisfactory results can be used to control the quality of the Chinese herbal composition.
实施例4Example 4
原料药配方为:按比例称取:连翘200g、金银花300g、板蓝根200g、大黄60g、广藿香60g、绵马贯众300g、红景天60g、薄荷脑9g、麻黄60g、苦杏仁100g、鱼腥草200g、甘草100g、石膏200g,按照以下工艺提取:The raw material formula is: scaled: 200g of Forsythia, 300g of honeysuckle, 200g of Radix, 60g of rhubarb, 60g of patchouli, 300g of Mianmaguan, 60g of Rhodiola, 9g of menthol, 60g of ephedra, 100g of bitter almond, Houttuynia cordata 200g, licorice 100g, gypsum 200g, extracted according to the following process:
(1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
(2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
(3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
(4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
(5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
(6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
(7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,装胶囊,即得。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed, and capsules are obtained.
含量测定方法:Method of determination:
供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加乙醇25mL,超声提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加乙醇25mL,超声处理30分钟,过滤,用乙醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of ethanol, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, and obtain filtrate Add the filter paper together with the residue into the stoppered conical flask, add 25mL of ethanol, sonicate for 30 minutes, filter, wash the dregs with ethanol 4 times, each time 5mL, combine the filtrate and washing solution twice, evaporate and dry, residue Dissolve with 50% methanol and dilute to 25mL, that is;
对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg 4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸 重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg 4,5-two a mixed solution of -O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycinate, wherein glycyrrhizic acid Weight = weight of ammonium glycyrrhizinate / 1.0207;
色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
Figure PCTCN2017075456-appb-000062
Figure PCTCN2017075456-appb-000062
检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为ACQUITY
Figure PCTCN2017075456-appb-000063
BEH shield RP 18;
The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column is ACQUITY
Figure PCTCN2017075456-appb-000063
BEH shield RP 18;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
结论:结果令人满意可以用于控制该中药组合物的质量。 Conclusion: Satisfactory results can be used to control the quality of the Chinese herbal composition.

Claims (14)

  1. 一种中药组合物的含量测定方法,该中药组合物的原料药包括:连翘、麻黄、大黄、鱼腥草、金银花、板蓝根、广藿香、绵马贯众、红景天、薄荷脑、苦杏仁、甘草、石膏,其特征在于,所述含量测定方法包括如下步骤:A method for determining the content of a traditional Chinese medicine composition, the raw material medicine of the traditional Chinese medicine composition comprises: forsythia, ephedra, rhubarb, houttuynia, honeysuckle, radix isatidis, patchouli, Mianma Guanzhong, Rhodiola, menthol, Bitter almond, licorice, gypsum, characterized in that the content determination method comprises the following steps:
    供试品溶液制备:取中药组合物,加有机溶剂提取,得供试品溶液;Preparation of the test solution: taking the traditional Chinese medicine composition, and extracting with an organic solvent to obtain a test solution;
    对照品溶液制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,加有机溶剂溶解,得对照品溶液;Preparation of reference solution: take appropriate amount of chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate , dissolved in an organic solvent to obtain a reference solution;
    色谱条件:以甲醇-乙腈-磷酸水溶液三元溶剂系统为流动相,梯度洗脱,所述磷酸水溶液浓度为0.1%~0.5%;Chromatographic conditions: using a methanol-acetonitrile-phosphoric acid aqueous solution ternary solvent system as a mobile phase, gradient elution, the concentration of the aqueous phosphoric acid solution is 0.1% to 0.5%;
    测定法:分别吸取对照品溶液与供试品溶液,注入液相色谱仪,测定,即得。Determination method: separately draw the reference solution and the test solution, inject into the liquid chromatograph, and measure, that is, obtain.
  2. 如权利要求1所述的含量测定方法,其特征在于,所述有机溶剂包括50%~100%的甲醇溶液、50%~100%的乙醇溶液。The content measuring method according to claim 1, wherein the organic solvent comprises 50% to 100% of a methanol solution and 50% to 100% of an ethanol solution.
  3. 如权利要求1所述的含量测定方法,其特征在于,所述梯度洗脱程序为:The method of determining content according to claim 1, wherein said gradient elution procedure is:
    Figure PCTCN2017075456-appb-100001
    Figure PCTCN2017075456-appb-100001
  4. 如权利要求1所述的含量测定方法,其特征在于,检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸。The method for determining content according to claim 1, wherein the detection wavelengths are 327 nm and 250 nm, respectively; quercetin and glycyrrhizic acid are detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, and different colors are detected at 327 nm. Forsythiaside A and 4,5-di-O-caffeoylquinic acid.
  5. 如权利要求1所述的含量测定方法,其特征在于,该中药组合物由如下重量份的原料药制成:连翘200-300、麻黄60-100、大黄40-60、鱼腥草200-300、金银花200-300、板蓝根200-300、广藿香60-100、绵马贯众200-300、红景天60-100、薄荷脑5-9、苦杏仁60-100、甘草60-100、石膏200-300;The content determination method according to claim 1, wherein the traditional Chinese medicine composition is prepared from the following raw materials by weight: Forsythia 200-300, Ephedra 60-100, Rhubarb 40-60, Houttuynia cordata 200- 300, honeysuckle 200-300, Banlangen 200-300, patchouli 60-100, Mianma Guanzhong 200-300, Rhodiola 60-100, menthol 5-9, bitter almond 60-100, licorice 60-100 , gypsum 200-300;
    所述含量测定方法为:The content determination method is:
    供试品溶液制备:取所述中药组合物0.5g,研细,精密称定,置具塞锥形瓶中,加乙醇或甲醇25mL,超声或者回流提取30分钟,过滤,得滤液,蒸干,残渣用乙醇或甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, grind finely, accurately weigh it, place it in a conical flask, add 25mL of ethanol or methanol, extract by ultrasonic or reflux for 30 minutes, filter, obtain filtrate, and dry it. , the residue is dissolved in ethanol or methanol and made up to 25mL, that is;
    对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg4,5-di- a mixed solution of O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
    色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
    Figure PCTCN2017075456-appb-100002
    Figure PCTCN2017075456-appb-100002
    Figure PCTCN2017075456-appb-100003
    Figure PCTCN2017075456-appb-100003
    检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为C18色谱柱;The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; the column is a C 18 column;
    测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  6. 如权利要求5所述的含量测定方法,其特征在于所述中药组合物由如下重量份的原料药制成:The content determination method according to claim 5, wherein the traditional Chinese medicine composition is made of the following raw materials by weight:
    连翘200、金银花300、板蓝根200、大黄40、广藿香60、绵马贯众300、红景天100、薄荷脑9、麻黄60、苦杏仁100、鱼腥草200、甘草100、石膏200。Forsythia 200, Honeysuckle 300, Banlangen 200, Rhubarb 40, Patchouli 60, Mianma Guanzhong 300, Rhodiola 100, Menthol 9, Ephedra 60, Bitter Almond 100, Houttuynia 200, Licorice 100, Gypsum 200 .
  7. 如权利要求5所述的含量测定方法,其特征在于所述中药组合物由如下重量份的原料药制成:The content determination method according to claim 5, wherein the traditional Chinese medicine composition is made of the following raw materials by weight:
    连翘300、金银花200、板蓝根300、大黄60、广藿香100、绵马贯众200、红景天60、薄荷脑5、麻黄100、苦杏仁60、鱼腥草300、甘草60、石膏300。Forsythia 300, Honeysuckle 200, Banlangen 300, Rhubarb 60, Patchouli 100, Mianma Guanzhong 200, Rhodiola 60, Menthol 5, Ephedra 100, Bitter Almond 60, Houttuynia 300, Licorice 60, Gypsum 300 .
  8. 如权利要求5所述的含量测定方法,其特征在于所述中药组合物由如下重量份的原料药制成:The content determination method according to claim 5, wherein the traditional Chinese medicine composition is made of the following raw materials by weight:
    连翘278、金银花294、板蓝根285、大黄55、广藿香95、绵马贯众290、红景天87、薄荷脑8.5、麻黄88、苦杏仁80、鱼腥草284、甘草95、石膏277。Forsythia 278, Honeysuckle 294, Banlangen 285, Rhubarb 55, Patchouli 95, Mianma Guanzhong 290, Rhodiola 87, Menthol 8.5, Ephedra 88, Bitter Almond 80, Houttuynia 284, Licorice 95, Gypsum 277 .
  9. 如权利要求5所述的含量测定方法,其特征在于所述中药组合物由如下重量份的原料药制成:The content determination method according to claim 5, wherein the traditional Chinese medicine composition is made of the following raw materials by weight:
    连翘255、金银花255、板蓝根255、大黄51、广藿香85、绵马贯众255、红景天85、薄荷脑7.5、麻黄85、苦杏仁85、鱼腥草255、甘草85、石膏255。Forsythia 255, Honeysuckle 255, Banlangen 255, Rhubarb 51, Patchouli 85, Mianma Guanzhong 255, Rhodiola 85, Menthol 7.5, Ephedra 85, Bitter Almond 85, Houttuynia 255, Licorice 85, Gypsum 255 .
  10. 如权利要求1-9任一项所述的含量测定方法,其特征在于所述中药组合物由以下步骤制成:The content determination method according to any one of claims 1 to 9, wherein the traditional Chinese medicine composition is produced by the following steps:
    (1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
    (2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
    (3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
    (4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
    (5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
    (6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
    (7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,密闭,混匀,压片或者装胶囊、或者装袋。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed, sealed, mixed, tableted or capsuled, or bagged.
  11. 如权利要求1-9任一项所述的含量测定方法,其特征在于所述含量测定方法为:The content determination method according to any one of claims 1 to 9, wherein the content determination method is:
    供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加50%乙醇25mL,超声提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加50%乙醇25mL,超声处理30分钟,过滤,用50%乙醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 50mL ethanol, 25mL, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, The filtrate was obtained, and the filter paper was added together with the residue into a stoppered conical flask, and 25 mL of 50% ethanol was added thereto, sonicated for 30 minutes, filtered, and the dregs were washed 4 times with 50% ethanol, 5 mL each time, and the filtrate and washing were combined twice. The liquid is evaporated to dryness, and the residue is dissolved in 50% methanol and made up to 25 mL, which is obtained;
    对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg4,5-di- a mixed solution of O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
    色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为: Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
    Figure PCTCN2017075456-appb-100004
    Figure PCTCN2017075456-appb-100004
    检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱:ACQUITY
    Figure PCTCN2017075456-appb-100005
    T3(1.8μm,2.1×100mm);柱温为35℃;
    The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column: ACQUITY
    Figure PCTCN2017075456-appb-100005
    T3 (1.8 μm, 2.1×100 mm); the column temperature is 35 ° C;
    测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  12. 如权利要求1-9任一项所述的含量测定方法,其特征在于所述含量测定方法为:The content determination method according to any one of claims 1 to 9, wherein the content determination method is:
    供试品溶液制备:取所述中药组合物0.5g,研细,精密称定,置具塞锥形瓶中,加50%甲醇25mL,超声提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加50%甲醇25mL,超声处理30分钟,过滤,用50%甲醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, grind finely, accurately weigh it, place it in a conical flask, add 50% methanol 25mL, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter The filtrate was obtained, and the filter paper was added together with the residue into a stoppered conical flask, and then 50 mL of 50% methanol was added thereto, sonicated for 30 minutes, filtered, and the dregs were washed 4 times with 50% methanol, 5 mL each time, and the filtrate was combined twice. The washing liquid is evaporated to dryness, and the residue is dissolved in 50% methanol and made up to 25 mL, which is obtained;
    对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg4,5-di- a mixed solution of O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
    色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
    Figure PCTCN2017075456-appb-100006
    Figure PCTCN2017075456-appb-100006
    检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为ACQUITY
    Figure PCTCN2017075456-appb-100007
    The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column is ACQUITY
    Figure PCTCN2017075456-appb-100007
    测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  13. 如权利要求1-9任一项所述的含量测定方法,其特征在于所述含量测定方法为:The content determination method according to any one of claims 1 to 9, wherein the content determination method is:
    供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加甲醇25mL,回流提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加甲醇25mL,超声处理30分钟,过滤,用甲醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of methanol, reflux extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, and obtain filtrate Add the filter paper together with the residue into a stoppered conical flask, add 25mL of methanol, sonicate for 30 minutes, filter, wash the dregs with methanol 4 times, each time 5mL, combine the filtrate and washing solution twice, evaporate and dry, residue Dissolve with 50% methanol and dilute to 25mL, that is;
    对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵 对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate The appropriate amount of the reference substance, accurately weighed, added 50% methanol to make 34.4 μg of fresh chlorogenic acid per 1 mL, 76.7 μg of chlorogenic acid, 34.2 μg of cryptochlorogenic acid, 56.2 μg of allosperglycin A, 14.9 μg 4,5- a mixed solution of di-O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
    色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
    Figure PCTCN2017075456-appb-100008
    Figure PCTCN2017075456-appb-100008
    检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为ACQUITY
    Figure PCTCN2017075456-appb-100009
    C18
    The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column is ACQUITY
    Figure PCTCN2017075456-appb-100009
    C 18 ;
    测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
  14. 如权利要求1-9任一项所述的含量测定方法,其特征在于所述含量测定方法为:The content determination method according to any one of claims 1 to 9, wherein the content determination method is:
    供试品溶液制备:取所述中药组合物0.5g研细,精密称定,置具塞锥形瓶中,加乙醇25mL,超声提取,功率500W,频率40kHz,提取30分钟,过滤,得滤液,将滤纸连同残渣一起加入具塞锥形瓶中,再加乙醇25mL,超声处理30分钟,过滤,用乙醇洗涤药渣4次,每次5mL,合并两次滤液及洗涤液,蒸干,残渣用50%甲醇溶解并定容至25mL,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, finely weigh it, place it in a conical flask, add 25mL of ethanol, ultrasonic extraction, power 500W, frequency 40kHz, extract for 30 minutes, filter, and obtain filtrate Add the filter paper together with the residue into the stoppered conical flask, add 25mL of ethanol, sonicate for 30 minutes, filter, wash the dregs with ethanol 4 times, each time 5mL, combine the filtrate and washing solution twice, evaporate and dry, residue Dissolve with 50% methanol and dilute to 25mL, that is;
    对照品溶液的制备:取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,精密称定,加50%甲醇制成每1mL含34.4μg新绿原酸、76.7μg绿原酸、34.2μg隐绿原酸、56.2μg异连翘酯苷A、14.9μg4,5-二-O-咖啡酰奎宁酸、11.2μg槲皮苷和42.8μg甘草酸铵的混合溶液,即得,其中,甘草酸重量=甘草酸铵重量/1.0207;Preparation of reference solution: taking fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, 4,5-di-O-caffeoyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance Appropriate amount, accurately weighed, add 50% methanol to make 34.4μg of new chlorogenic acid per 1mL, 76.7μg chlorogenic acid, 34.2μg cryptochlorogenic acid, 56.2μg of allosperglycin A, 14.9μg4,5-di- a mixed solution of O-caffeoylquinic acid, 11.2 μg of quercetin and 42.8 μg of ammonium glycyrrhizinate, wherein, the weight of glycyrrhizic acid = weight of ammonium glycyrrhizinate / 1.0207;
    色谱条件:以甲醇-乙腈-0.1%磷酸溶液为流动相,梯度洗脱程序为:Chromatographic conditions: methanol-acetonitrile-0.1% phosphoric acid solution as mobile phase, gradient elution procedure is:
    Figure PCTCN2017075456-appb-100010
    Figure PCTCN2017075456-appb-100010
    检测波长分别为327nm和250nm;250nm下检测槲皮苷和甘草酸,327nm下检测新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A和4,5-二-O-咖啡酰奎宁酸;色谱柱为ACQUITY
    Figure PCTCN2017075456-appb-100011
    shield RP 18;
    The detection wavelengths were 327 nm and 250 nm respectively; quercetin and glycyrrhizic acid were detected at 250 nm, and new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A and 4,5-di-O-coffee were detected at 327 nm. Acyl quinic acid; column is ACQUITY
    Figure PCTCN2017075456-appb-100011
    Shield RP 18;
    测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入液相色谱仪,测定,记录色谱图,即得。 Determination method: respectively, accurately draw 2 μL of the reference solution and the test solution, inject into the liquid chromatograph, measure and record the chromatogram, that is, obtain.
PCT/CN2017/075456 2016-03-03 2017-03-02 Method for determining component contents of chinese medicine composition WO2017148418A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610119792.3A CN107149623B (en) 2016-03-03 2016-03-03 Content determination method of traditional Chinese medicine composition
CN201610119792.3 2016-03-03

Publications (1)

Publication Number Publication Date
WO2017148418A1 true WO2017148418A1 (en) 2017-09-08

Family

ID=59742544

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/075456 WO2017148418A1 (en) 2016-03-03 2017-03-02 Method for determining component contents of chinese medicine composition

Country Status (2)

Country Link
CN (1) CN107149623B (en)
WO (1) WO2017148418A1 (en)

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109187820A (en) * 2018-11-09 2019-01-11 湖南国华制药有限公司 The method for building up and its finger-print of a kind of compound formula chinaroot greenbrier granules UPLC finger-print and application
CN109459507A (en) * 2018-10-24 2019-03-12 重庆第二师范学院 The measuring method of phenolic acid compound in one vegetable oil
CN109541086A (en) * 2018-11-16 2019-03-29 怀化学院 The effective component determination of diamond vine extract and the method for quality control of drug
WO2019091287A1 (en) * 2017-11-10 2019-05-16 石家庄以岭药业股份有限公司 Method for separating eight components in chinese traditional medicine composition
CN110118834A (en) * 2019-05-23 2019-08-13 贵州远程制药有限责任公司 A kind of quality determining method for phlegm asthma pharmaceutical composition
CN111175386A (en) * 2018-11-13 2020-05-19 天津现代创新中药科技有限公司 Content determination method of Xiebai powder
CN111175392A (en) * 2019-12-31 2020-05-19 江西杏林白马药业股份有限公司 Quality control method of cough-relieving loquat syrup
CN111323416A (en) * 2020-04-22 2020-06-23 西安培华学院 Preparation and application methods of test paper for detecting antioxidant
CN111693620A (en) * 2020-05-20 2020-09-22 太极集团重庆涪陵制药厂有限公司 Composition for judging quality of Jinshuihuijun decoction and detection method
CN111912911A (en) * 2019-05-07 2020-11-10 孙国栋 Method for determining content of effective components in honeysuckle antipyretic mixture by HPLC method
CN112345675A (en) * 2020-12-07 2021-02-09 葵花药业集团湖北武当有限公司 HPLC method for simultaneously detecting 8 active ingredients in infantile Magan granules
CN112816428A (en) * 2020-12-31 2021-05-18 四川新绿色药业科技发展有限公司 Method for identifying standard decoction of fructus Gardeniae, parched fructus Gardeniae and parched fructus Gardeniae
CN112834672A (en) * 2020-12-31 2021-05-25 四川新绿色药业科技发展有限公司 Construction and detection method of rangooncreeper fruit formula particle characteristic spectrum
CN112858491A (en) * 2019-11-12 2021-05-28 北京以岭药业有限公司 Rhodiola rosea medicinal material fingerprint spectrum determination method
CN112903844A (en) * 2021-01-19 2021-06-04 皖西学院 Detection method for content of pteridophytin in fiddlehead
CN112924572A (en) * 2021-01-21 2021-06-08 上海中医药大学 In-vivo and in-vitro multi-component analysis method of radix stephaniae tetrandrae and radix astragali decoction
CN113049727A (en) * 2021-03-08 2021-06-29 哈尔滨瀚邦医疗科技有限公司 Method for detecting polysorbate 80 content
CN113109476A (en) * 2021-04-15 2021-07-13 岛津企业管理(中国)有限公司 Double-gradient system in liquid chromatogram and matched elution program setting method thereof
CN113138238A (en) * 2021-04-15 2021-07-20 河南省纳普生物技术有限公司 Method for detecting content of 8 flavone and phenolic acid components in camelina sativa seeds
CN113156017A (en) * 2021-04-26 2021-07-23 陕西汉王药业股份有限公司 Method for simultaneously determining contents of 12 chemical components in strong dizzy-stop tablet by adopting HPLC (high performance liquid chromatography)
CN113237961A (en) * 2020-11-18 2021-08-10 上海和黄药业有限公司 Method for detecting main drug effect components of cinnamon and storax in pharmaceutical preparation
CN113376273A (en) * 2021-06-02 2021-09-10 国药集团精方(安徽)药业股份有限公司 Detection method of HPLC (high performance liquid chromatography) characteristic spectrum of Qingxin lotus seed drink and application of characteristic spectrum
CN113509530A (en) * 2019-07-11 2021-10-19 深圳弘汇生物医药有限公司 A Chinese medicinal compound preparation for treating asthma, and its preparation method and quality control method
CN113720935A (en) * 2021-08-25 2021-11-30 海南医学院 Method for measuring content of epicatechin in snake-soaked tendon
CN113740198A (en) * 2021-08-17 2021-12-03 马应龙药业集团股份有限公司 Method for determining yellow vaseline content in Mayinglong musk hemorrhoid ointment
CN113933437A (en) * 2021-11-08 2022-01-14 山东省饲料兽药质量检验中心 Method for simultaneously detecting multiple components in multiple traditional Chinese medicine extracts by using UPLC-PDA (ultra-performance liquid chromatography-personal digital Assistant)
CN114027503A (en) * 2021-11-29 2022-02-11 乐泰药业有限公司 Composition with auxiliary protection function on chemical liver injury and quality evaluation method thereof
CN114113395A (en) * 2021-11-26 2022-03-01 中山百灵生物技术股份有限公司 Method for detecting ethyl p-toluenesulfonate in obeticholic acid
CN114235980A (en) * 2021-11-16 2022-03-25 武汉人福创新药物研发中心有限公司 Method for detecting content of flavonoid compounds in desmodium styracifolium extract
CN114252545A (en) * 2021-12-22 2022-03-29 国药集团冯了性(佛山)药业有限公司 HPLC detection method for paeoniflorin content in bailing tablets
CN114295756A (en) * 2021-12-31 2022-04-08 江苏七○七天然制药有限公司 Content detection method of 'Anchuan' tablets
CN114460191A (en) * 2022-01-20 2022-05-10 广西壮族自治区食品药品检验所 Method for measuring content of digitoxin D in Tianwang heart tonifying preparation
CN114515301A (en) * 2020-11-19 2022-05-20 国药集团同济堂(贵州)制药有限公司 Flatstem milkvetch seed standard decoction, preparation method and detection method
CN114609298A (en) * 2022-03-30 2022-06-10 湖南中医药大学 Method for determining content of triterpenic acid compounds in poria cocos and application of triterpenic acid compounds
CN114689711A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Construction and detection method of Baoyinjian characteristic spectrum
CN114689712A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for channel warming decoction extract
CN114689776A (en) * 2020-12-31 2022-07-01 四川新绿色药业科技发展有限公司 Construction method of high performance liquid phase characteristic spectrum of combined spicebush root decoction
CN114689710A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for loquat lung-clearing drink extract
CN114689780A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for Baoyin decoction extract
CN114740114A (en) * 2022-04-14 2022-07-12 广西特色作物研究院 Method for identifying extremely-low-cold-demand peach germplasm resources
CN114847415A (en) * 2021-02-04 2022-08-05 山西中医药大学 Functional traditional Chinese medicine bait for preventing influenza
CN115266955A (en) * 2021-04-29 2022-11-01 景忠山国药(唐山)有限公司 Method for detecting content of ingredients in deafness capsule based on one-test-multiple evaluation method
CN115343388A (en) * 2022-08-04 2022-11-15 中山市中医院 Method for evaluating quality of sophora japonica particles by using one-test-multiple evaluation method
CN115372520A (en) * 2022-09-20 2022-11-22 贵州医科大学 Blood-entering component and component distribution determination method of litsea cubeba oil
CN115389654A (en) * 2022-08-04 2022-11-25 华润三九现代中药制药有限公司 Method for constructing fingerprint spectrum of centipeda minima medicinal preparation and content testing method
CN114184700B (en) * 2021-12-06 2023-08-22 内蒙古民族大学 Method for measuring chemical component content of Mongolian medicine costa
CN113341015B (en) * 2021-06-04 2023-09-22 国家烟草质量监督检验中心 Method for determining triazole fungicide in plant-derived food
CN116990420A (en) * 2023-09-27 2023-11-03 江西中医药大学 Feature-map-based honey bran fructus aurantii comprehensive quality evaluation method
CN117233306A (en) * 2023-11-16 2023-12-15 江西省药品检验检测研究院 Fingerprint establishment and component content determination method for jindan Fuyan particles
WO2024011923A1 (en) * 2022-07-14 2024-01-18 神威药业集团有限公司 Method for determining content of a plurality of effective components in yigong powder and use thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109668970B (en) * 2017-10-13 2020-11-10 石家庄以岭药业股份有限公司 Ultra-high performance liquid chromatography detection method for traditional Chinese medicine composition
CN107677750A (en) * 2017-11-01 2018-02-09 广西壮族自治区食品药品检验所 The multicomponent content assaying method of Mussaenda hirsutula
CN111830170A (en) * 2020-07-24 2020-10-27 陕西康城药业股份有限公司 Method for measuring content of antiviral mixture in four seasons
CN112684059A (en) * 2021-01-08 2021-04-20 贵州大学 Method for detecting chemical components of rhododendron pseudobulb based on UPLC-ESI-MS
CN113406225B (en) * 2021-06-11 2023-03-10 上海上药杏灵科技药业股份有限公司 Multi-component analysis method for standing circle
CN115718145A (en) * 2021-08-24 2023-02-28 河北以岭医药研究院有限公司 Method for measuring fingerprint spectrum of traditional Chinese medicine composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1483463A (en) * 2003-07-01 2004-03-24 河北以岭医药研究院有限公司 Anti-virus Chinese medicine composition and preparation process thereof
WO2011095802A1 (en) * 2010-02-02 2011-08-11 Generics [Uk] Limited Hplc method for analyzing sunitinib
CN103800523A (en) * 2012-11-13 2014-05-21 河北以岭医药研究院有限公司 Method for preparing anti-virus traditional Chinese medicinal composition and finger-print detection method
CN104345111A (en) * 2013-08-08 2015-02-11 河北以岭医药研究院有限公司 Determination method for content of multiple active compositions in traditional Chinese medicine composition preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104101657B (en) * 2013-04-02 2017-04-12 石家庄以岭药业股份有限公司 Method for determining content of multiple components in Chinese medicinal composition preparation
CN104345110B (en) * 2013-08-08 2017-06-16 河北以岭医药研究院有限公司 Seven kinds of content assaying methods of composition in a kind of Chinese medicinal composition preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1483463A (en) * 2003-07-01 2004-03-24 河北以岭医药研究院有限公司 Anti-virus Chinese medicine composition and preparation process thereof
WO2011095802A1 (en) * 2010-02-02 2011-08-11 Generics [Uk] Limited Hplc method for analyzing sunitinib
CN103800523A (en) * 2012-11-13 2014-05-21 河北以岭医药研究院有限公司 Method for preparing anti-virus traditional Chinese medicinal composition and finger-print detection method
CN104345111A (en) * 2013-08-08 2015-02-11 河北以岭医药研究院有限公司 Determination method for content of multiple active compositions in traditional Chinese medicine composition preparation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BROLIS, M. ET AL.: "Identification by High-Performance Liquid Chromatography-Diode Array Detection-Mass Spectrometry and Quantification by Highperformance Liquid Chromatography-UV Absorbance Detection of Active Constituents of Hypericum Perforatum", JOURNAL OF CHROMATOGRAPHY A, 31 December 1998 (1998-12-31), pages 9 - 16 *
LIU, MINYAN ET AL.: "Simultaneous Content Determination of 5 Active Compounds in Lianhua Qingwen Capsules by UPLC", CHINA PHARMACY, vol. 24, no. 44, 31 December 2013 (2013-12-31), pages 4201 - 4203 *
YANG, ZHIFANG ET AL.: "Determination of Hyperoside, Isoquerditrin and Quercitrin-3'-Glucoside in Flos Abelmoschus Manihot of Different Areas by HPLC", PHARMACEUTICAL JOURNAL OF CHINESE PEOPLE'S LIBERATION ARMY, vol. 21, no. 5, 31 October 2005 (2005-10-31), pages 388 - 389 *
ZHANG, YONGFENG ET AL.: "Rapid Determination of Ingredients in Water Extract of Lianhua Qingwen Capsule by UPLC", CHINESE JOURNAL OF MODERN APPLIED PHARMACY, vol. 31, no. 1, 31 January 2014 (2014-01-31), pages 78 - 80, XP055414053 *

Cited By (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2769512C2 (en) * 2017-11-10 2022-04-01 Шицзячжуан Илин Фармасьютикал Ко., Лтд. Method for isolating eight compounds from composition based on chinese medicine drugs
WO2019091287A1 (en) * 2017-11-10 2019-05-16 石家庄以岭药业股份有限公司 Method for separating eight components in chinese traditional medicine composition
US11564966B2 (en) 2017-11-10 2023-01-31 Shijiazhuang Yiling Pharmaceutical Co., Ltd. Method for separating eight components in Chinese traditional medicine composition
CN109459507A (en) * 2018-10-24 2019-03-12 重庆第二师范学院 The measuring method of phenolic acid compound in one vegetable oil
CN109187820B (en) * 2018-11-09 2021-07-23 湖南国华制药有限公司 Method for establishing UPLC fingerprint of compound formula chinaroot greenbrier granules
CN109187820A (en) * 2018-11-09 2019-01-11 湖南国华制药有限公司 The method for building up and its finger-print of a kind of compound formula chinaroot greenbrier granules UPLC finger-print and application
CN111175386B (en) * 2018-11-13 2022-04-05 天津现代创新中药科技有限公司 Content determination method of Xiebai powder
CN111175386A (en) * 2018-11-13 2020-05-19 天津现代创新中药科技有限公司 Content determination method of Xiebai powder
CN109541086A (en) * 2018-11-16 2019-03-29 怀化学院 The effective component determination of diamond vine extract and the method for quality control of drug
CN111912911A (en) * 2019-05-07 2020-11-10 孙国栋 Method for determining content of effective components in honeysuckle antipyretic mixture by HPLC method
CN110118834B (en) * 2019-05-23 2021-07-30 贵州远程制药有限责任公司 Quality detection method for phlegmatic asthma medicine composition
CN110118834A (en) * 2019-05-23 2019-08-13 贵州远程制药有限责任公司 A kind of quality determining method for phlegm asthma pharmaceutical composition
CN113509530A (en) * 2019-07-11 2021-10-19 深圳弘汇生物医药有限公司 A Chinese medicinal compound preparation for treating asthma, and its preparation method and quality control method
CN112858491B (en) * 2019-11-12 2024-03-12 北京以岭药业有限公司 Rhodiola rosea medicinal material fingerprint spectrum determination method
CN112858491A (en) * 2019-11-12 2021-05-28 北京以岭药业有限公司 Rhodiola rosea medicinal material fingerprint spectrum determination method
CN111175392A (en) * 2019-12-31 2020-05-19 江西杏林白马药业股份有限公司 Quality control method of cough-relieving loquat syrup
CN111175392B (en) * 2019-12-31 2022-05-03 江西杏林白马药业股份有限公司 Quality control method of cough-relieving loquat syrup
CN111323416B (en) * 2020-04-22 2023-01-06 西安培华学院 Preparation and application methods of test paper for detecting antioxidant
CN111323416A (en) * 2020-04-22 2020-06-23 西安培华学院 Preparation and application methods of test paper for detecting antioxidant
CN111693620B (en) * 2020-05-20 2022-05-31 太极集团重庆涪陵制药厂有限公司 Composition for judging quality of Jinshuihuijun decoction and detection method
CN111693620A (en) * 2020-05-20 2020-09-22 太极集团重庆涪陵制药厂有限公司 Composition for judging quality of Jinshuihuijun decoction and detection method
CN113237961A (en) * 2020-11-18 2021-08-10 上海和黄药业有限公司 Method for detecting main drug effect components of cinnamon and storax in pharmaceutical preparation
CN114515301B (en) * 2020-11-19 2024-03-29 国药集团同济堂(贵州)制药有限公司 Semen astragali Complanati standard decoction, and preparation method and detection method thereof
CN114515301A (en) * 2020-11-19 2022-05-20 国药集团同济堂(贵州)制药有限公司 Flatstem milkvetch seed standard decoction, preparation method and detection method
CN112345675B (en) * 2020-12-07 2022-08-05 葵花药业集团湖北武当有限公司 HPLC method for simultaneously detecting 8 active ingredients in infantile Magan granules
CN112345675A (en) * 2020-12-07 2021-02-09 葵花药业集团湖北武当有限公司 HPLC method for simultaneously detecting 8 active ingredients in infantile Magan granules
CN114689712A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for channel warming decoction extract
CN114689711B (en) * 2020-12-29 2023-09-08 四川新绿色药业科技发展有限公司 Construction and detection method of yin-preserving decoction characteristic spectrum
CN114689711A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Construction and detection method of Baoyinjian characteristic spectrum
CN114689710A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for loquat lung-clearing drink extract
CN114689780B (en) * 2020-12-29 2023-10-03 四川新绿色药业科技发展有限公司 Multi-component quality detection method for Baoyin decoction extract
CN114689710B (en) * 2020-12-29 2023-10-03 四川新绿色药业科技发展有限公司 Multi-component quality detection method for loquat lung-heat-clearing drink extract
CN114689712B (en) * 2020-12-29 2023-10-03 四川新绿色药业科技发展有限公司 Multi-component quality detection method for channel warming soup extract
CN114689780A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for Baoyin decoction extract
CN112834672B (en) * 2020-12-31 2023-09-08 四川新绿色药业科技发展有限公司 Construction and detection method of feature map of rangooncreeper fruit formula granule
CN112816428B (en) * 2020-12-31 2023-09-08 四川新绿色药业科技发展有限公司 Identification method of standard decoction of fructus gardeniae, fried fructus gardeniae and coked fructus gardeniae
CN114689776B (en) * 2020-12-31 2023-05-26 四川新绿色药业科技发展有限公司 Construction method of high-efficiency liquid-phase characteristic spectrum of lindera root decoction
CN114689776A (en) * 2020-12-31 2022-07-01 四川新绿色药业科技发展有限公司 Construction method of high performance liquid phase characteristic spectrum of combined spicebush root decoction
CN112834672A (en) * 2020-12-31 2021-05-25 四川新绿色药业科技发展有限公司 Construction and detection method of rangooncreeper fruit formula particle characteristic spectrum
CN112816428A (en) * 2020-12-31 2021-05-18 四川新绿色药业科技发展有限公司 Method for identifying standard decoction of fructus Gardeniae, parched fructus Gardeniae and parched fructus Gardeniae
CN112903844A (en) * 2021-01-19 2021-06-04 皖西学院 Detection method for content of pteridophytin in fiddlehead
CN112924572A (en) * 2021-01-21 2021-06-08 上海中医药大学 In-vivo and in-vitro multi-component analysis method of radix stephaniae tetrandrae and radix astragali decoction
CN114847415A (en) * 2021-02-04 2022-08-05 山西中医药大学 Functional traditional Chinese medicine bait for preventing influenza
CN113049727B (en) * 2021-03-08 2024-04-26 哈尔滨瀚邦医疗科技有限公司 Method for detecting content of polysorbate 80
CN113049727A (en) * 2021-03-08 2021-06-29 哈尔滨瀚邦医疗科技有限公司 Method for detecting polysorbate 80 content
CN113109476A (en) * 2021-04-15 2021-07-13 岛津企业管理(中国)有限公司 Double-gradient system in liquid chromatogram and matched elution program setting method thereof
CN113138238A (en) * 2021-04-15 2021-07-20 河南省纳普生物技术有限公司 Method for detecting content of 8 flavone and phenolic acid components in camelina sativa seeds
CN113109476B (en) * 2021-04-15 2023-10-13 岛津企业管理(中国)有限公司 Dual gradient system in liquid chromatograph and matched elution program setting method thereof
CN113156017A (en) * 2021-04-26 2021-07-23 陕西汉王药业股份有限公司 Method for simultaneously determining contents of 12 chemical components in strong dizzy-stop tablet by adopting HPLC (high performance liquid chromatography)
CN115266955A (en) * 2021-04-29 2022-11-01 景忠山国药(唐山)有限公司 Method for detecting content of ingredients in deafness capsule based on one-test-multiple evaluation method
CN113376273B (en) * 2021-06-02 2023-03-17 国药集团精方(安徽)药业股份有限公司 Detection method of HPLC (high performance liquid chromatography) characteristic spectrum of Qingxin lotus seed drink and application of characteristic spectrum
CN113376273A (en) * 2021-06-02 2021-09-10 国药集团精方(安徽)药业股份有限公司 Detection method of HPLC (high performance liquid chromatography) characteristic spectrum of Qingxin lotus seed drink and application of characteristic spectrum
CN113341015B (en) * 2021-06-04 2023-09-22 国家烟草质量监督检验中心 Method for determining triazole fungicide in plant-derived food
CN113740198B (en) * 2021-08-17 2024-03-08 马应龙药业集团股份有限公司 Method for measuring yellow vaseline content in musk hemorrhoid ointment
CN113740198A (en) * 2021-08-17 2021-12-03 马应龙药业集团股份有限公司 Method for determining yellow vaseline content in Mayinglong musk hemorrhoid ointment
CN113720935A (en) * 2021-08-25 2021-11-30 海南医学院 Method for measuring content of epicatechin in snake-soaked tendon
CN113933437A (en) * 2021-11-08 2022-01-14 山东省饲料兽药质量检验中心 Method for simultaneously detecting multiple components in multiple traditional Chinese medicine extracts by using UPLC-PDA (ultra-performance liquid chromatography-personal digital Assistant)
CN113933437B (en) * 2021-11-08 2023-06-20 山东省饲料兽药质量检验中心 Method for simultaneously detecting multiple components in multiple traditional Chinese medicine extracts by using UPLC-PDA
CN114235980A (en) * 2021-11-16 2022-03-25 武汉人福创新药物研发中心有限公司 Method for detecting content of flavonoid compounds in desmodium styracifolium extract
CN114235980B (en) * 2021-11-16 2024-06-11 武汉人福创新药物研发中心有限公司 Method for detecting flavonoid content in desmodium styracifolium extract
CN114113395B (en) * 2021-11-26 2023-10-31 中山百灵生物技术股份有限公司 Method for detecting ethyl p-toluenesulfonate in obeticholic acid
CN114113395A (en) * 2021-11-26 2022-03-01 中山百灵生物技术股份有限公司 Method for detecting ethyl p-toluenesulfonate in obeticholic acid
CN114027503A (en) * 2021-11-29 2022-02-11 乐泰药业有限公司 Composition with auxiliary protection function on chemical liver injury and quality evaluation method thereof
CN114184700B (en) * 2021-12-06 2023-08-22 内蒙古民族大学 Method for measuring chemical component content of Mongolian medicine costa
CN114252545A (en) * 2021-12-22 2022-03-29 国药集团冯了性(佛山)药业有限公司 HPLC detection method for paeoniflorin content in bailing tablets
CN114295756A (en) * 2021-12-31 2022-04-08 江苏七○七天然制药有限公司 Content detection method of 'Anchuan' tablets
CN114460191A (en) * 2022-01-20 2022-05-10 广西壮族自治区食品药品检验所 Method for measuring content of digitoxin D in Tianwang heart tonifying preparation
CN114609298A (en) * 2022-03-30 2022-06-10 湖南中医药大学 Method for determining content of triterpenic acid compounds in poria cocos and application of triterpenic acid compounds
CN114609298B (en) * 2022-03-30 2024-05-10 湖南中医药大学 Method for measuring content of triterpenic acid compounds in poria cocos and application of method
CN114740114A (en) * 2022-04-14 2022-07-12 广西特色作物研究院 Method for identifying extremely-low-cold-demand peach germplasm resources
CN114740114B (en) * 2022-04-14 2023-05-26 广西特色作物研究院 Method for identifying peach germplasm resources with extremely low cold requirement
WO2024011923A1 (en) * 2022-07-14 2024-01-18 神威药业集团有限公司 Method for determining content of a plurality of effective components in yigong powder and use thereof
CN115343388B (en) * 2022-08-04 2023-09-08 中山市中医院 Method for evaluating quality of pagodatree flower particles by using one-test-multiple-evaluation method
CN115389654A (en) * 2022-08-04 2022-11-25 华润三九现代中药制药有限公司 Method for constructing fingerprint spectrum of centipeda minima medicinal preparation and content testing method
CN115343388A (en) * 2022-08-04 2022-11-15 中山市中医院 Method for evaluating quality of sophora japonica particles by using one-test-multiple evaluation method
CN115389654B (en) * 2022-08-04 2023-10-27 华润三九现代中药制药有限公司 Construction method and content testing method of fingerprint of centipeda minima medicinal preparation
CN115372520A (en) * 2022-09-20 2022-11-22 贵州医科大学 Blood-entering component and component distribution determination method of litsea cubeba oil
CN116990420A (en) * 2023-09-27 2023-11-03 江西中医药大学 Feature-map-based honey bran fructus aurantii comprehensive quality evaluation method
CN117233306B (en) * 2023-11-16 2024-01-30 江西省药品检验检测研究院 Fingerprint establishment and component content determination method for jindan Fuyan particles
CN117233306A (en) * 2023-11-16 2023-12-15 江西省药品检验检测研究院 Fingerprint establishment and component content determination method for jindan Fuyan particles

Also Published As

Publication number Publication date
CN107149623A (en) 2017-09-12
CN107149623B (en) 2021-03-12

Similar Documents

Publication Publication Date Title
WO2017148418A1 (en) Method for determining component contents of chinese medicine composition
WO2017148426A1 (en) Method for determining fingerprint of chinese medicine composition
CN108896673B (en) Method for determining content of chlorogenic acid, luteolin and apigenin in spider fruits
CN107991425B (en) Detection method of traditional Chinese medicine composition for treating traumatic injury
CN106822203B (en) Radix angelicae pubescentis granules and preparation method and quality control method thereof
CN102269752B (en) Detection method for pharmaceutical composition preparation
CN104090036B (en) A kind of enrichment and the method detecting low concentration Anthraquinones effective constituent
CN112014498A (en) Method for detecting content of triterpene component in swertia mileensis tablet
CN109655558B (en) Method for detecting effective part group of periploca forrestii schltr
CN109085285B (en) Quality control method of changyanning granules
CN101791366A (en) Method for testing quality of Discorea nipponica Makino in different places and medicinal materials of same genera
CN108020613B (en) Method for measuring content of menthol in traditional Chinese medicine composition
CN110108827B (en) Method for simultaneously determining eight active ingredients in antipyretic and antitoxic tablet
CN101926889A (en) Method for detecting white paeony root-medlar particles
CN108414667B (en) Method for detecting quality standard of Shengui Yixin granules
CN104345108B (en) Qualitative quantitative determination method for liver-heat-clearing tablet
CN106596777B (en) The method of quality control of Dandengtongnao preparation
CN110687224B (en) Method for measuring triptolide A in tripterygium wilfordii medicinal material and tripterygium wilfordii multi-glycoside tablet prepared from tripterygium wilfordii medicinal material
CN113655166A (en) High performance liquid detection method for 14 components in golden flower refreshing granules
CN108614066A (en) A kind of Traditional Chinese medicine composition detection method for treating coronary heart disease
CN113252830A (en) Risk assessment method for pyrrolizidine alkaloid in gynura segetum
CN111965269A (en) Method for measuring oleanolic acid content and ursolic acid content in patrinia heterophylla by using ultra-high performance liquid chromatography
CN111948331A (en) Quality detection method of sugar-free liver-clearing granules
CN112843124A (en) Preparation method and quality standard of salvia miltiorrhiza formula granules
CN113201037B (en) Compound and Xian Mao Biaozhun decoction containing same

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17759269

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17759269

Country of ref document: EP

Kind code of ref document: A1